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Members of the genus Mycobacterium contain species that are adapted to thrive under a wide 
variety of environmental conditions. A key factor in the life cycle of mycobacteria is their 
ability to persist in the absence of growth triggered by either low oxygen levels or nutrient 
limitation. During these transitions from growth to non-growth, mycobacteria are faced with 
the challenge of redox homeostasis and balancing electron flux to meet maintenance energy 
requirements. Mycobacteria are able to synthesize a large number of flavoproteins and have 
biosynthetic pathways for a number of flavins (e.g. FMN, FAD and F420) that vary in redox 
potential.  In this study, I have investigated the molecular function of two flavoproteins in the 
fast-growing saprophyte Mycobacterium smegmatis: a flavin-sequestering protein (Fsq) and 
malate menaquinone oxidoreductase (Mqo).  Analysis of Fsq showed it was a member of the 
diverse superfamily of flavin and deazaflavin-dependent oxidoreductases (FDORs) and was 
widely distributed in mycobacterial species. I created a markerless deletion mutant of fsq and 
demonstrated that fsq is required for cell survival during hypoxia. Using fsq deletion and 
overexpression, I found that fsq enhances cellular resistance to hydrogen peroxide treatment. 
We solved the X-ray crystal structure of Fsq to 2.7 Å revealing a homodimeric organization 
with FAD bound noncovalently. The Fsq structure also uncovered no potential substrate-
binding cavities, as the FAD is fully enclosed, and electrochemical studies indicated that the 
Fsq:FAD complex is relatively inert and does not share common properties with electron-
transfer proteins. Taken together, our results suggest that Fsq modulates the formation of 
reactive oxygen species (ROS) by sequestering free FAD during recovery from hypoxia, 
thereby protecting the cofactor from undergoing autoxidation to produce ROS. This finding 
represents a new paradigm in mycobacterial adaptation to hypoxia.  
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The physiological role of Mqo in mycobacteria is unknown despite its high conservation 
throughout the mycobacterial genera. Mqo serves the role of oxidizing malate to oxaloacetate 
and is a highly conserved member of the tricarboxylic acid (TCA) cycle within mycobacteria. 
Genetic deletion of mqo revealed that mqo was essential for growth on non-fermentable 
carbon sources, and delayed growth was observed on fermentable carbon sources. 
Biochemical analyses showed that deletion of mqo resulted in significant alteration in the 
activity of other enzymes in the TCA cycle and electron transport chain. Further, the oxygen 
consumption of the Dmqo mutant was reduced and displayed an inability to increase oxygen 
consumption upon addition of an uncoupler. Growth of the Dmqo mutant on fermentable 
carbon sources resulted in significantly lower pH levels in the growth medium, which was 
partially caused by the secretion of malate. Taken together these data suggest that the deletion 
of mqo in M. smegmatis causes the operation of an incomplete TCA cycle that can be 
bypassed on fermentable carbon sources. 
 
The results of this thesis provide insight in M. smegmatis flavoprotein function and advance 
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Chapter 1. Introduction  
  
 2 
1.1. Metabolism and persistence  
1.1.1. Basis of energy generation 
Over the advancement of life different forms of energy generation for the purpose of both 
growth and persistence have evolved. Bacteria obtain energy input from two different sources 
with phototrophs deriving it from light and chemotrophs from either organic (heterotrophy) 
or inorganic (lithotrophy) substances. Both processes then convert these energy inputs into 
reducing equivalents such as NADH and NADPH, which are then oxidised to yield ATP, the 
key source of energy within the cell. The hydrolysis of ATP to ADP yields a significant 
output of energy (DG -30.5 kJ mol-1), which is sufficient to drive many vital reactions within 
the cell (Peters et al. 2016). The three ways in which cells can generate ATP are substrate 
level phosphorylation (SLP), oxidative phosphorylation and recently discovered electron 
bifurcation (Peters et al. 2016). 
 
The simplest form of ATP re-generation, SLP is the process where the transfer of phosphoryl 
groups is directly coupled to an enzymatic conversion of a substrate. Commonly SLP occurs 
through glycolysis and yields 2 ATP (net) per glucose broken down. Some organisms utilise 
SLP in order to grow without oxidative phosphorylation in a process called fermentation. 
Fermentation is not very efficient, given the relatively low yields of ATP per molecule of 
glucose, however in situations where bacterial cells lack a terminal electron acceptor for the 
electron transport chain (ETC) it allows for continued growth and/or survival. The downside 
to fermentative growth is the products produced as a result (commonly lactic acid or ethanol) 
build up and eventually become toxic to the cell, some organisms overcome this by 
producing a diffusible gas such as hydrogen or hydrogen sulfide.   
More recently electron bifurcation has been recognised as method of ATP generation (Peters 
et al. 2016). Electron bifurcation simply consists of the coupling of a thermodynamically 
favourable reaction to one that is thermodynamically unfavourable using the normally lost 
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energy from the favourable reaction to drive the unfavourable reaction (Peters et al. 2016). 
Enzymes such as bifurcating hydrogenases allow more efficient SLP with 4 ATP being 
generated per molecule of glucose (Peters et al. 2016). 
 
The more complicated form of ATP re-generation, oxidative phosphorylation is the 
generation of an ion gradient across a membrane using an ETC with a terminal acceptor. This 
is then coupled to ATP synthesis through the use of the ion gradient to drive a membrane 
bound ATP synthase. This is the most efficient method for generating ATP with 30-36 ATP 
being generated in mitochondria per molecule of glucose, This stoichiometry is variable in 
prokaryotes with the make-up of the ETC largely being the determining factor (Rich 2003). 
The ETC that powers oxidative phosphorylation consists of complexes, which input electrons 
to quinones, which are then shuttled to terminal electron acceptors. Throughout this electron 
transfer, ions (generally protons, although sometimes sodium ions) are transported across the 
membrane through complexes using the energy obtained from the reactions they perform. 
Organisms making use of oxidative phosphorylation are described as respirers. Respiration 
can occur in two forms; anaerobic, the use of a terminal electron acceptor other than oxygen 
(i.e. nitrate) or aerobic, the use of oxygen as the terminal electron acceptor. 
 
1.1.2. Reactive oxygen species  
One of the costs of the development of oxygen-dependent life is that oxygen can react with 
many components of the cell in undesirable ways resulting in the formation of reactive 
oxygen species (ROS). ROS include superoxide, hydrogen peroxide, hydroxyl radicals and 
oxygen singlets. One of the primary drivers of ROS generation are the members of the ETC 
with electron leakage being a primary driver (Wallace 2008). In complex I, this is thought to 
be driven through the formation of superoxide at both the quinone-binding site and the FMN 
reaction site (Treberg et al. 2011). Similarly, Complex II also drives the formation of ROS 
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though the flavin adenine dinucleotide (FAD) site, when it operates in either the oxidative or 
reductive direction (Quinlan et al. 2012). Lastly, complex III has been shown to generate 
superoxide through its Q cycle (Quinlan et al. 2011). The ETC is thought to be responsible 
for as much as 87% of the ROS generated in the cell, however other mechanisms do exist 
(Cabiscol et al. 2000). The other mechanisms of ROS formation usually involve other 
molecules with sufficient electrochemical potential to catalyse a reaction to a ROS (Massey 
1994). Commonly these reactions involve autoxidation of molecules such as flavins, metal 
ions (iron, copper), and many other biological compounds (Miller et al. 1990). The biological 
significance of the non-ETC ROS reactions is currently unknown due to the difficulty in 
studying ROS and determining the contribution of non-ETC ROS to total cell ROS (Turrens 
2003). 
 
One of the primary cellular components damaged by ROS is lipids, with polyunsaturated 
lipids being directly targeted by free radicals, which results in lipid peroxidation (Figure 1.1) 
(Cabiscol et al. 2000). Lipid peroxidation results in changes in membrane fluidity thereby 
effecting membrane-associated proteins (Cabiscol et al. 2000) such as the members of the 
ETC, which then in turn produce more ROS resulting in a dangerous positive feedback loop. 
Another primary target of ROS is DNA, with the sugar and base groups being targeted by 
radicals causing single and double stranded breaks which can crosslink to other molecules 
resulting in lesions that can block transcription and replication (Figure 1.1) (Cabiscol et al. 
2000). If the DNA repair machinery then incorrectly repairs the damage, it can cause 
deleterious mutations for the cell. The third target of ROS is proteins themselves through the 
process of modification of their amino-acids, co-factors, disulfide bond formation and metal 
groups (Figure 1.1) (Cabiscol et al. 2000).  
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As all of the damage caused by ROS is undesirable to the cell, consequently removal and 
mitigation mechanisms have been evolved by aerobic organisms. One example of ROS 
removal common across both eukaryotes and prokaryotes is superoxide dismutase, which 
catalyses the reaction of superoxide to hydrogen peroxide and oxygen (Abreu and Cabelli 
2010). The hydrogen peroxide is then broken down into water and oxygen by catalases 
(Chelikani et al. 2004). Another mechanism of mitigating ROS stress is the molecule 
glutathione (GSH), which reduces disulfide bonds formed on cystines of proteins resulting in 
GSH being oxidised to form glutathione disulphide (GSSH). GSSH can then be recycled 
back to GSH by glutathione reductase (Couto et al. 2013). Given the significant costs of ROS 
stress responses, organisms such as Escherichia coli have established means of sensing the 
presence of ROS and upregulating response genes. The two regulators in E. coli are the OxyR 
and SoxRS (Cabiscol et al. 2000). SoxR is activated by oxidation of its iron sulfur cluster 
through redox-cycling drugs and the regulon may not be responsible for mitigating ROS 
stress (Gu and Imlay 2011). OxyR is activated when a disulphide bond forms between two 
cysteine residues (Jo et al. 2015). As part of the OxyR response regulon, glutaredoxin and 
glutathione reductases are upregulated. These two proteins work in partnership with GSH to 





Figure 1.1. Damage caused by reactive oxygen species in E. coli 
Autoxidation of enzymes produces hydrogen peroxide and superoxide. Superoxide 
dismutases and catalases reduce the accumulation of these oxidants. Hydrogen peroxide 
species damage DNA by reacting with the pool of ferrous iron that associates with it causing 
lesions. Both oxidants damage iron sulfur clusters and non-nuclear iron enzymes. Both 
oxidants are thought to cause peroxidation of bacterial membranes. Generally basal 
production of these oxidants is kept in check by cell defences, however once an exogenous 
source of these oxidants is added inducible systems such as OxyR and SoxRS are required to 








1.1.3. Bacterial adaptation and persistence 
The ability to adapt and change to the environment to ensure the survival of the organism has 
been fundamental to proliferation of bacteria. These changes are largely mediated at the 
transcriptional level, with sensor kinases perceiving environmental changes and altering gene 
expression (either up or down), to adapt or survive in the new or changed environment. One 
example of adaptation to a change in the environment is the E. coli aerobic-anaerobic 
response regulatory system, which has two primary regulators ArcAB and FNR (Gunsalus 
and Park 1994). ArcAB is a classic two component regulatory system, with a sensor kinase 
and DNA-binding regulatory protein capable of activating/repressing genes (Ronson et al. 
1987). ArcAB consists of a transmembrane sensor capable of autophosphorylation (ArcB) 
when sensing a change in the redox state of a cell and a DNA-binding protein (ArcA) which 
is transphosphorylated by ArcB. ArcA is activated by ArcB when there is low/no oxygen in 
the cell causing the repression of genes such as those responsible for the tricarboxcylic acid 
(TCA) cycle, facilitating the switch to anaerobic metabolism (Iuchi and Weiner 1996).  
 
FNR is both a sensor and regulator with an iron sulfur cluster that directly senses oxygen. In 
the presence of oxygen, the oxidation state of the iron sulfur cluster is changed subsequently 
causing conformational changes which inactivate FNR ([2Fe–4S] FNR) (Unden et al. 2002). 
When FNR is activated by the iron sulfur clusters being reduced by GSH ([4Fe–4S] FNR), 
FNR upregulates the genes responsible for fumarate and nitrate reductase as well as a host of 
other genes involved in anaerobic metabolism. Fumarate and nitrate are alternative electron 
acceptors for the ETC thereby allowing the cell to continue to use the more efficient 
oxidative phosphorylation in anaerobic conditions.   
 
Adaptation of bacteria through direct sensing can sometimes not be quick enough to react or 
be unable to detect a change in the environment. This has led to many bacterial populations 
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developing a strategy of having a proportion of cells in a different state, so called “bet-
hedging”. The bet-hedging strategy relies on stochastic variations in gene expression to 
differentiate cells into different states (Grimbergen et al. 2015). An example of bet-hedging 
can be found within the stringent response in E. coli. Micro-starvation or stochastic variations 
within one of the regulatory genes spoT and relA with their regulatory partners (dskA) have 
been shown to trigger the stringent response when the population of cells is not starved 
(Korch et al. 2003, Amato et al. 2014). There are multiple mechanisms through which the 
stringent response is believed to trigger persister formation, many of which involve toxin-
antitoxin systems (Harms et al. 2016). The stringent response is believed to upregulate a gene 
called obg, which in turn triggers the HokB-SokB type I toxin-antitoxin module resulting in a 
collapsed membrane potential and the cells entry into dormancy (Verstraeten et al. 2015). 
However, more recently the role of toxin-antitoxin systems in the stringent response persister 
formation has been called into question, with a prophage believed to be responsible for many 
of the toxin-antitoxin mediated phenotypes (Harms et al. 2017). Despite the question of 
toxin-antitoxin involvement, it is still believed that random triggering of the stringent 
response results in persister cell formation (Harms et al. 2017). 
 
Persister cells can be broadly classified into the type I and type II persister cells. The 
difference between these types is how they are generated with type I persister cells being 
created by a trigger event (i.e direct sensing of the environment) such as starvation or oxygen 
depletion; whereas type II persister are generated throughout growth through bet-hedging 
strategies (Balaban et al. 2004). Persister cells are tolerant to many clinically relevant 
antibiotics and therefore survive the initial treatment and can spontaneously revert back to 
normal causing a relapse of infection. Additionally, as persister cells can survive in the 
presence of antibiotics, they can develop resistance through genetic mutations.   
 
 9 
1.1.4. Interplay between metabolism and persistence 
As discussed, one of the primary drivers of the formation of persister cells is starvation 
resulting from a lack of either amino acids, a carbon source, or the lack of a terminal electron 
acceptor (e.g. oxygen). Starvation causes the cell to become metabolically inactive with 
energy only generated for maintenance and repair, which has led to a goal of new treatment 
methods for bacterial infection targeting the energy-generating machinery. 
 
1.2. Mycobacteria 
Mycobacteria are rod shaped (0.3-0.5 µm in diameter) aerobic bacteria that have shown the 
ability to tolerate hypoxic conditions for periods of time. Classically, members of the 
Mycobacterium genus possess a thicker cell wall that is hydrophobic and rich in mycolic 
acids, which results in the bacteria being acid fast when stained using a Ziehl–Neelsen stain 
(Hartmans et al. 2006). Mycobacteria can be divided into two groups, the fast growers, which 
are more commonly described as being non-pathogenic except to the immunocompromised, 
and the slow growers, which include the major disease-causing mycobacteria (King et al. 
2017). It is currently estimated that there are over 180 species within the Mycobacterium 
genus, with the majority residing in soil and water environments utilising organic compounds 
in a saprophytic lifestyle (Hartmans et al. 2006, King et al. 2017, Gupta et al. 2018). Given 
the large size of the Mycobacterium genus, there has been debate as to whether the genus 
should be divided into 5 genera based on molecular markers (Gupta et al. 2018). 
Mycobacterium smegmatis is a fast growing, non-pathogenic, environmental mycobacterium 
species (Gordon and Smith 1953). M. smegmatis takes 3-4 days to form single visible 
colonies on solid agar (Akinola 2013). The growth and safety characteristics combine to 
make M. smegmatis an ideal molecular model for studying mycobacterial physiology and 
metabolism.  
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1.2.1. Mycobacterium tuberculosis  
Mycobacterium tuberculosis is the most prevalent of the disease-causing slow growing 
mycobacteria with new cases arising estimated to be 10.4 million each year and killing an 
estimated 1.7 million people each year (World Health Organisation 2016). M. tuberculosis 
spreads through aerosols produced by infected individuals coughing, spitting and sneezing. 
Following inhalation of the M. tuberculosis cells, alveolar macrophages (AMs) ingest the 
bacilli and attempt to kill the M. tuberculosis thereby halting the infection (Sasindran and 
Torrelles 2011). However, M. tuberculosis has developed mechanisms to escape the 
bactericidal effects of the AMs and survive in the cell. These mechanisms include triggering 
an anti-inflammatory response, decreasing the acidity of the phagosome and blocking 
reactive oxygen and nitrogen intermediate production (Sasindran and Torrelles 2011). After 
M. tuberculosis has evaded the initial immune response, M. tuberculosis multiplies inside the 
AMs causing the destruction of AMs, resulting in the recruitment of blood monocytes and an 
inflammatory response. Once the blood monocytes mature and recruit activated T 
lymphocytes, the formation of an early stage granuloma occurs. The continuing T cell 
activation results in the formation of a granuloma initiating the latent stage of M. tuberculosis 
infection (Sasindran and Torrelles 2011). Granulomas prevent the infection from progressing 
through a combination of an immune response and creating an unfavourable environment for 
growth of the M. tuberculosis. One key environmental change is the reduction of oxygen 
levels (hypoxia), which has been shown in studies on guinea pigs, rabbits and non-human 
primates (Via et al. 2008). It is thought based on gene expression data, that hypoxic 
granulomas also occur in humans (Fenhalls et al. 2002). This ability of M. tuberculosis to 
suspend cellular growth and become dormant is a major barrier to the treatment of the disease 
as it prolongs the time required for effective sterilisation of the M. tuberculosis from the 
body. Understanding how mycobacteria adapt to hypoxic environments may provide insight 
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into potential drug targets that specifically target the cells in this dormant (non-replicating) 
state. 
 
Currently people with M. tuberculosis infections are treated with combinations of antibiotics.  
First line agents consist of rifampicin, isoniazid, pyrazinamide and ethambutol. Recently, a 
larger number of cases have presented with resistance to one or more of these first line 
antibiotics. These cases are referred to as multi-drug resistant (MDR) M. tuberculosis and 
present a significant challenge to treat as second line antibiotics require longer treatment 
times. If M. tuberculosis infection is resistant to the second line antibiotics it is then referred 
to as extensively drug-resistant (XDR). Presently, the treatment of XDR M. tuberculosis is 
limited to a few compounds that have significant side effects and questionable efficacy. One 
of these compounds used on XDR and MDR M. tuberculosis is Bedaquiline (BDQ). It was 
the first new antibiotic discovered for M. tuberculosis since 1971 and targets the F1 F0-ATP 
synthase (Andries et al. 2005, Preiss et al. 2015). BDQ represents a new class of antibiotic, 
which directly targets the energy generating machinery that cells rely on to grow, survive and 
persist. 
 
1.3. Mycobacterial metabolism, adaptation and persistence 
1.3.1. Mycobacterial metabolism 
Mycobacteria are obligate aerobes (Wilson et al. 1999), but have the extraordinary ability to 
persist in the absence of oxygen. In the absence of oxygen fermentative processes (e.g 
succinate secretion and H2 production) have been identified (Boshoff and Barry 2005, 
Watanabe et al. 2011, Berney et al. 2014). The currently accepted model for mycobacterial 
energy generation is that mycobacteria requires the use of an ETC and therefore utilises 
oxidative phosphorylation as its driver of energy production for growth. SLP is used in 
mycobacteria to make ATP but it is incapable of fuelling growth (Tran and Cook 2005). The 
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F1 Fo-ATP synthase has been shown to be essential on both fermentable and non-fermentable 
carbon sources, which is unusual compared to other bacteria (Tran and Cook 2005). The 
reason for this essentiality remains largely unknown. 
 
In mycobacteria, the electron donating complexes of the ETC consist of a type 1 NADH 
dehydrogenase, a type 2 NADH dehydrogenase, a succinate dehydrogenase (Sdh), a malate 
quinone oxidoreductase (Mqo) and various hydrogenases not found in pathogenic 
mycobacteria (Figure 1.2). The type 1 and type 2 NADH dehydrogenases couple NADH 
oxidation to menaquinone reduction. The type 1 NADH dehydrogenase has been shown to be 
non-essential for growth while at least one type 2 is required, however the type 1 has been 
implicated in mediating survival in macrophages (Miller et al. 2010, Vilcheze et al. 2018). 
The obligate requirement of a type 2 NADH dehydrogenase for growth has led to a push for 
the development of small molecule inhibitors that target it (Harbut et al. 2018). Sdh couples 
the TCA cycle to oxidative phosphorylation by coupling the oxidation of succinate to 
fumarate to the reduction of menaquinone.  In organisms such as E. coli, complex II requires 
a helper protein called SdhE to assist in the formation of the covalent bond between the FAD, 
however no homolog has been found in mycobacteria (McNeil et al. 2012). Both 
M. tuberculosis and M. smegmatis have two Sdh enzymes with M. tuberculosis also having a 
fumarate reductase (Frd) (Cook et al. 2014). In M. smegmatis, Sdh2 has been proposed to be 
essential illustrating the importance of these enzymes to mycobacteria (Pecsi et al. 2014). 
There is debate if the Sdh2 in M. smegmatis and M. tuberculosis is capable, given the right 
physiological pressure, to act as a Frd, however no biochemical evidence of this exists (Cook 
et al. 2017).  
 
The mycobacterial terminal electron acceptors are predominantly the two cytochrome 
oxidases cytochrome bd and the cytochrome bcc-aa3 super complex (Gong et al. 2018). 
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These complexes couple menaquinol oxidation to the reduction of oxygen to water. The 
cytochrome bcc-aa3 super complex is more efficient than cytochrome bd, resulting in 6 
protons transported across the membrane (Figure 1.2). Cytochrome bd has been suggested to 
be utilised primarily under low oxygen conditions due to its purported increased affinity to 
oxygen (Berney and Cook 2010). Other than using oxygen as a terminal electron acceptor, 
some mycobacteria (M. tuberculosis) can also utilise fumarate through a Frd and nitrate 






Figure 1.2 The electron transport chain of M. smegmatis.  




The tricarboxylic acid cycle (TCA) (Figure 1.3) is a critical carbon cycle found throughout 
many of the organisms of life. One key branch point in the TCA cycle is the glyoxylate shunt 
which uses isocitrate lyase to produce glyoxylate and succinate from isocitrate. The 
glyoxylate is then further converted by malate synthase to malate utilising acetyl-CoA. The 
glyoxylate shunt is critical for the remodelling of the TCA cycle, which occurs during 
hypoxia to produce more succinate helping maintain the membrane potential (Eoh and Rhee 
2013). There are two isocitrate lyases in M. smegmatis and M. tuberculosis (icl1, icl2) 
(Figure 1.3), which also function as methyl isocitrate lyases important for the breakdown of 
propionyl-CoA generated from b-oxidation of fatty acids (Upton and McKinney 2007). It is 
still debated as to which of the icl1 and icl2 functions is more important for the viability of 
M. tuberculosis (Marrero et al. 2010). The malate synthase has been shown to be a critical 
part of the glyoxalate shunt as glyoxylate is toxic when it builds up and malate synthase is 
responsible for its removal (Puckett et al. 2017). Overall, the glyoxylate shunt has been 
shown to be critical for mycobacterial metabolic adaptability. 
 
Mycobacteria diverge significantly from what is normally present in the TCA cycle after the 
generation of α-ketoglutarate as they lack a typical α-ketoglutarate dehydrogenase (Tian et al. 
2005). Instead, they employ an α-ketoglutarate ferredoxin oxidoreductase (korAB) usually 
found in anaerobic bacteria, which converts α-ketoglutarate to succinyl-CoA (Baughn et al. 
2009). The korAB-dependent pathway is uninhibited by glyoxylate from the glyoxylate shunt 
unlike the alternative pathway (Baughn et al. 2009), which uses an α-ketoglutarate 
decarboxylase (kgd (HAOS)) to produce succinate semialdehyde that can then be converted 
by the succinate semialdehyde dehydrogenases (gabD1, gabD2) into succinate (Tian et al. 
2005). The HOAS pathway has been shown to be critical for the mitigation of the build-up of 
toxic succinate semialdehyde when cells are using glutamate (Maksymiuk et al. 2015). The 
third alternative pathway at the α-ketoglutarate branch point is that of the GABA shunt, 
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which provides entry into the TCA cycle for glutamate and has been implicated in pH 
homeostasis (Feehily and Karatzas 2013).  
 
M. tuberculosis is capable of running a reductive TCA cycle under low oxygen conditions in 
order to re-oxidise co-factors such as NADH and to provide fumarate as a terminal electron 
acceptor (Watanabe et al. 2011). This process involves the conversion of pyruvate to 
oxaloacetate, which is then reduced to malate through malate dehydrogenase (Mdh). The 
malate is then dehydrated to fumarate, which can be used by Frd as a terminal electron 
acceptor for the ETC (Watanabe et al. 2011). Critically in M. smegmatis, there is no Mdh or 
Frd meaning that this process is unlikely to occur (Figure 1.3). Mdh is required for the 
reductive TCA cycle to occur as the alternative enzyme for the catalysis of malate to 
oxaloacetate, Mqo, can only function in the forward direction. M. smegmatis has developed 
alternative ways of surviving reductive stress. One method M. smegmatis uses involves its 
three hydrogenases (which are not present in M. tuberculosis) for H2 production as an energy 
source for the purpose of regenerating NADH, or as an electron acceptor (Berney et al. 2014, 
Berney et al. 2014, Greening et al. 2014). 
 
Three enzymes are involved in the malate-oxaloacetate flux step of the TCA cycle. The three 
enzymes, malic enzyme (mez), phosphoenolpyruvate carboxykinase (pckA) and pyruvate 
carboxylase (pca) form part of the anaplerotic node (Sauer and Eikmanns 2005)(Figure 1.3). 
The anaplerotic node feeds back to PEP, the start point for gluconeogenesis, playing a critical 
role in metabolism (Sauer and Eikmanns 2005, Marrero et al. 2010, Basu et al. 2018). Both 
Pck and Mez catalyse reversible reactions, while Pca can only catalyse carboxylation (Sauer 
and Eikmanns 2005). Pck has been shown to be essential for mycobacterial growth on fatty 
acids, in macrophages and in mouse lungs (Marrero et al. 2010). Mez has been implicated in 
mycolic acid localisation where an altered cell wall and increased accumulation of free 
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mycolic acid is seen when mez is deleted (Basu et al. 2018). Overall, the anaplerotic node is 
clearly an essential pathway for gluconeogenesis in mycobacteria as well as creating 
metabolic intermediates for other pathways (Marrero et al. 2010, Basu et al. 2018). 
 
1.3.2. Malate quinone oxidoreductases  
Mqo catalyses the oxidation of malate to oxaloacetate while reducing quinone and thus 
providing a link between the ETC and the TCA cycle (Figure 1.3). In order to drive this 
reaction, Mqo requires FAD as a cofactor (Imai and Tobari 1977). In E. coli, the primary 
enzyme for malate to oxaloacetate conversion is malate dehydrogenase, despite the fact they 
possess a Mqo enzyme (van der Rest et al. 2000). However, in the more closely related (to 
mycobacteria) Corynebacterium glutamicum, the opposite effect is observed with Mqo being 
the primary enzyme (Molenaar et al. 2000). In M. smegmatis, Mqo combined with a 
M. tuberculosis copy of Mdh can function as an alternative Ndh-2 because when Mqo is 
combined with Mdh in the reverse direction they achieve the same functional outcome as 
Ndh-2 (Vilcheze et al. 2005). Given the current desire to create drugs that target Ndh-2 (Cook 
et al. 2017), further understanding of the role of Mqo in mycobacterial metabolism is critical 
to avoid unwanted reroutes of bacterial metabolism. Overall, Mqo enzymes are understudied 






Figure 1.3. The TCA cycle of mycobacteria with genes or protein complexes associated 
with catalysing the reactions.  
Genes and protein complexes present in M. tuberculosis only in red, genes and protein 
complexes present in M. smegmatis only in yellow, genes and protein complexes present in 





1.3.3. Mycobacteria and reactive oxygen species 
Mycobacteria employ both SOD and catalases as mechanisms to eliminate ROS (Piddington 
et al. 2001, Ng et al. 2004). In addition, they also use phenolicglycolipid to scavenge ROS 
(Flynn and Chan 2001). In contrast to other bacteria, mycobacteria use mycothiol in place of 
GSH (discussed in section 1.1.2) (Buchmeier and Fahey 2006). Mycothiol is functionally 
analogous to GSH and is found across actinobacteria (Buchmeier and Fahey 2006). The 
existence of these mechanisms suggests mycobacteria have evolved a diverse array of 
mechanisms for eliminating and controlling levels of ROS. 
 
1.3.4. Mycobacterial adaptation to oxygen 
The ability of mycobacteria to adapt and change to environmental changes has seen their 
expansion into a diverse set of microbial habitats (e.g. soil, water, humans and many 
animals). To be able to dominate such diverse environments has required mycobacteria to 
have the ability to sense the environment and adapt to change. To do this, mycobacteria not 
only use two component regulators, but also serine/threonine kinases, often more commonly 
found in eukaryotes (Wehenkel et al. 2006). One of the more well understood and relevant 
systems is the mycobacterial dormancy system DosR, which in M. tuberculosis consists of 
two sensor kinases DosS and DosT and the DNA response regulator DosR. The two sensor 
kinases both rely on heme groups for sensing with the iron group playing the pivotal role 
(Kumar et al. 2007). The DosS sensor has been shown to have a preference for sensing redox 
state and this is thought to be indirectly sensing the menaquinone pool (MQ/MQH2) of the 
ETC (Honaker et al. 2010). DosT directly senses oxygen concentration in the cell with the 
sensor being inactive when oxygen is bound (Kumar et al. 2007). Interestingly, both sensors 
can be activated by direct binding of nitric oxide or carbon monoxide (Kumar et al. 2007). 
Other mycobacteria diverge in their sensor kinases such as M. smegmatis, with only one of 
 
 20 
the sensor kinases, DosS, which behaves like the M. tuberculosis DosT (Kim et al. 2010). 
The reason for this divergence in a number of kinases is unknown. Following activation, the 
sensor kinases auto-phosphorylate, then transfer the phosphate to the aspartate 54 of DosR to 
activate it (Park et al. 2003). DosR is then able to bind its 18 bp palindromic recognition 
sequence to activate 48 genes in M. tuberculosis and 49 genes in M. smegmatis (Park et al. 
2003, Berney et al. 2014). 
The DosR regulon includes important alternative redox cycling enzymes such as hydrogenase 
3 (Group 3b) in M. smegmatis, thereby providing a link between metabolism and DosR (Park 
et al. 2003, Berney et al. 2014). There is no direct regulation from DosR or WhiB3 (another 
oxygen sensing regulator) on any of the regular ETC genes leading to questions on how the 
regular ETC is adjusted under hypoxic conditions (Cook et al. 2014). Related to the ETC 
NarK, a nitrate transporter is regulated by DosR, however the nitrate reductase is not 
regulated by DosR (Park et al. 2003). Many genes within the DosR regulon which are 
conserved between mycobacterial species (Park et al. 2003, Berney et al. 2014). One example 
is tgs1, which encodes a triacylglycerol synthase responsible for the generation of 
triacylglycerol, the proposed energy source during hypoxic survival (Daniel et al. 2004). 
Given tgs1’s high conservation throughout mycobacteria it is clear that triacylglycerol plays a 
critical role in the modified metabolism used in hypoxia. Many of the other reported DosR 
regulon genes currently have no functional assignment and it is unclear what physiological 
role they play. 
 
Regulation of the TCA cycle is poorly understood in mycobacteria. One protein that has been 
shown to regulate the ETC is the cAMP receptor protein (Crp). In E. coli, Crp responds to the 
levels of cyclic AMP within the cell (Green et al. 2014). When depletion of a carbon source 
occurs, activation of adenylyl cyclase occurs leading to increased levels of cAMP. The cAMP 
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then binds to Crp forming the cAMP-CRP binary complex, that binds a consensus sequence 
to regulate downstream genes (Fic et al. 2009). Crp has been shown to regulate Sdh and 
cytochrome bd in M. smegmatis in either a cAMP dependent or independent manner (Aung et 
al. 2014, Aung et al. 2015). Also, the regulation of cytochrome bd under hypoxic conditions 
is by Crp (Aung et al. 2014, Aung et al. 2015). Clearly, Crp can provide a link between 
metabolism and the availability of oxygen in mycobacteria. 
1.3.5. Mycobacterial persistence 
Further understanding of mycobacterial persistence is critical given the role this process plays 
in disease and drug tolerance/resistance. One of the models used to trigger mycobacteria to 
enter a persistence state is gradual oxygen depletion commonly through the Wayne model 
(Wayne and Hayes 1996). The importance of DosR for long term persistence is still debated 
as the cell is still capable of entering the enduring hypoxic response (EHR), although there 
seems to be a consensus that triacylglycerol generation is critical (Rustad et al. 2008, Deb et 
al. 2009). More recent work has indicated that DosR may be connected to the EHR through 
the transcription factors that it regulates (Sun et al. 2018). The DosR and EHR response allow 
the cell to enter a state of non-replicating persistence (NRP). Cells that are in these 
persistence states have a higher intrinsic tolerance to antibiotics, so require increased 
treatment times and therefore have an increased chance of gaining antibiotic resistance 
(Wayne and Hayes 1996). Gaining further understanding of how DosR, the EHR and 
mycobacterial metabolism work together to create persistence cells will allow for the more 
targeted development of antibiotics that can enhance the death rate of the persister cells 




1.4. Flavins and Flavoproteins 
Flavin molecules are a fundamental co-factor required for many of the reactions of life. The 
primary group of flavins are the riboflavins, which consist of flavin mononucleotide (FMN) 
and FAD. Riboflavins have the ability to catalyse both one and two electron transfer reactions 
owing to the chemistry of the isoalloxazine ring. Riboflavin (vitamin B2) is the key precursor 
to flavins and can either be synthesised by the organism if it has the required metabolic 
pathways or obtained exogenously. FMN is synthesised from riboflavin by riboflavin kinase, 
which attaches a phosphate group to the ribityl sidechain (Figure 1.4) (Macheroux et al. 
2011). FAD is then generated from the FMN by FAD synthetase that attaches an adenine 
nucleotide to the ribityl phosphate sidechain (Figure 1.4) (Macheroux et al. 2011). In 
prokaryotes such as mycobacteria the synthesis of FAD and FMN is carried out by a single 
bifunctional enzyme (RibF) (Vitreschak 2002). 
 
 In general, either FMN or FAD exist primarily as a protein cofactor, which is either 
covalently bound (10% of proteins) or non-covalently bound (90% of proteins) (Macheroux 
et al. 2011). Proteins containing FAD or FMN are colloquially referred to as flavoproteins 
and represent between 0.1 and 3.5% of predicted genes (Macheroux et al. 2011). About 75% 
of flavoproteins, utilise FAD over FMN as their cofactor (Macheroux et al. 2011). Some 
flavoproteins are members of the ETC discussed earlier, such as type 1 NADH 
dehydrogenase with a FMN, type 2 NADH dehydrogenases with a FAD, Sdh with a FAD and 
Mqo with a FAD. The fact that a majority of the ETC enzymes are flavoprotein illustrates 
how import to life FMN and FAD based chemistry is. Further, flavoproteins are critical 
enzymes involved in mitigating ROS stress such as FAD-dependent glutathione reductase 
(Mittl and Schulz 1994). In addition to catalysing reactions, flavoproteins can also act as 




Flavins and flavoproteins have the propensity to undergo undesirable chemical reactions such 
as producing ROS or catalysing reactions the cell does not desire. Evolution has driven 
flavoproteins to be optimised for their desired chemical reaction while minimising any off-
target reactions, however reactions with oxygen appear to be largely unavoidable. Examples 
of flavoproteins having unavoidable reactions with oxygen are the reactions catalysed by 
Sdh, Frd and NADH dehydrogenase with oxygen at their riboflavin site (Messner and Imlay 
2002). Between reactions with flavoproteins and other cofactors such as iron sulfur clusters, 
cells have been forced to develop strategies post ROS formation (as discussed in section 










In addition to riboflavins some forms of life can produce 5-deazaflavin molecules which have 
a carbon substituted for the N5 atom of the isoalloxazine ring (Figure 1.4). The most 
biologically relevant of these is F420, which while structurally similar to the two riboflavins 
(Figure 1.4) is functionally distinct because it is an obligate two electron carrier and functions 
more like a nicotinamide (e.g. NADH) (Greening et al. 2016). Another major difference is 
that its redox potential is -340 mV compared to -220 mV for FAD and -190 for FMN 
(Greening et al. 2016). F420 was originally identified in methane producing archaea and then 
in sulfate-reducing archaea more than 50 years ago, leading to substantial understanding of 
the role of F420 in these organisms (Greening et al. 2016). However relatively more recently 
F420 has been found in bacteria such as mycobacteria, but our understanding of its role in 
these organisms remains poor (Greening et al. 2016). It is speculated that they may substitute 
for NAD(P)H allowing for greater metabolic flexibility in stressed environments (Greening et 
al. 2016). 
 
Mycobacteria possess FAD, FMN and F420 leading to the term being coined that 
mycobacteria have flavin-rich lifestyles (Macheroux et al. 2011). Currently there is a surge in 
the study of flavoproteins in mycobacteria owing to the discovery that a nitroimidazole 
derivative antibiotic functions through the use of the F420-dependent enzyme Ddn 
(Feuerriegel et al. 2011). This renewed interest is also leading to the desire to better 
understand the function of the flavoproteins that have no described function as they may 
present new drug targets for cells in a persister state.   
 
1.4.1. Flavin deazaflavin oxidoreductases  
Flavin deazaflavin oxidoreductases (FDORs) are a diverse family of proteins with a diverse 
range of functions. The FDOR family are characterised by their split b-barrel structural shape 
that is usually associated with a co-factor-binding pocket and often, but not always a 
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substrate binding site. The FDOR family is split into three families; the FDOR-A family, the 
FDOR-AA family that has F420 as a cofactor, and the more diverse FDOR-B family that has 
F420, FAD and FMN as cofactors (Ahmed et al. 2015). Within the families, the FDOR 
proteins can be further split into at least 14 subclasses illustrating the remarkable diversity of 
these proteins (Ahmed et al. 2015). The FDOR’s are particularly abundant in Actinobacteria, 
in particular the mycobacterium genus with up to 30 FDORs present in a single species, 
however the physiological role of many remains to be elucidated (Ahmed et al. 2015).  
 
A member of FDOR-A family Ddn has been suggested to have a role in the activation of 
bicyclic 4′-nitroimidazole antibiotics (e.g. Delamanid) (Feuerriegel et al. 2011). The 
physiological role of Ddn is suspected to be as a quinone reductase coupling oxidation F420H2 
to the reduction of menaquinone in order to prevent cytotoxic semiquinones (Gurumurthy et 
al. 2013). The physiological reaction of Ddn has been investigated, but how Ddn impacts 
cellular function and survival of the cell remains to be elucidated despite Ddn homologs 
being highly conserved (Gurumurthy et al. 2013). The FDOR-AA roles are not currently 
understood apart from being implicated interacting with lipids (Ahmed et al. 2015).  
 
The FDOR-B family share sequence and structural homology with PnPOx proteins involved 
in vitamin B synthesis, however, the functions of most FDOR-B proteins remain largely 
unknown, except for a class of unique biliverdin reductases (Ahmed et al. 2016). The FDOR 
biliverdin reductase catalyses biliverdin to bilirubin using F420 in a manner structurally and 
mechanically distinct from NADH/NADPH biliverdin reductases (Ahmed et al. 2016). In 
addition to these biologically relevant reactions, FDOR proteins have been shown to have 
promiscuous activity on quinones, coumarins, pyrones, pyrans, cyclohexenones, and 
triarylmethanes, which may provide a use for these proteins in industry (Greening et al. 
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2017). Recently, it was identified that an FDOR, which binds FAD, was part of the dosR 
regulon in M. smegmatis and M. tuberculosis (Berney et al. 2014, Ahmed et al. 2015).  
 
1.5. Overview 
This thesis focuses on understanding the physiological roles of two important flavoproteins 
within mycobacteria. The first flavoprotein is MSMEG_5243 (Fsq), which has previously 
been shown to bind FAD and is a member of the DosR regulon (Berney et al. 2014, Ahmed 
et al. 2015). Fsq currently has no known physiological role. In chapter 2, I describe that Fsq 
functions as a flavin sequestering protein to mitigate hypoxic and oxidative stress. In chapter 
3 I examine the effect of Fsq on Sdh in mycobacteria. The second flavoprotein we investigate 
is malate quinone oxidoreductase (Mqo). Mqo catalyses the oxidation of malate to 
oxaloacetate while reducing quinone, however the importance of Mqo on mycobacterial 
metabolism has not been examined previously. In Chapter 4 I investigate the importance of 
Mqo on mycobacterial metabolism and growth. Together this work on Fsq and Mqo aimed to 
give greater insight into the roles of two flavoproteins in mycobacteria that are thought to be 
important for growth and adaptation to environmental stress. 
 
1.6. Aims of this study 
1. To determine the functional role of the FDOR Fsq (MSMEG_5243) and homologs 
within M. smegmatis using the following strategies 
Objective 1: Create a non-polar deletion mutant of fsq.  
Objective 2: Assay the effect deletion of fsq has on growth and survival. 
Objective 3: Use the structure of the Fsq protein produced by our collaborators 
to gain a greater understanding of how the structure of Fsq relates to its 
physiological role. 
Objective 4: Overexpress fsq and assaying the effect on growth and survival. 
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Objective 5: Examine the influence that Fsq has on Sdh (FAD-dependent 
flavoprotein). 
2. To investigate the role Mqo plays in the growth of M. smegmatis using the following 
strategies 
Objective 1: Create a marked deletion mutant of mqo using a phage-based 
deletion method. 
Objective 2: Assay the effect that deletion of mqo has on growth. 
Objective 3: Determine what effect the deletion of mqo has on the activity of 
proteins in the ETC using enzyme activity assays. 
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The ability to persist in the absence of growth triggered by low oxygen levels is a critical 
process for the survival of mycobacterial species in a variety of environmental niches. 
MSMEG_5243 (fsq), a gene of unknown function in Mycobacterium smegmatis, is 
upregulated in response to hypoxia and regulated by DosR-DosS/DosT, an oxygen and redox 
sensing two-component system that is highly conserved in mycobacteria. In this 
communication we demonstrate that MSMEG_5243 is a Flavin Sequestering protein and is 
henceforth referred to as Fsq. We show here that Fsq is a member of the diverse superfamily 
of flavin and deazaflavin-dependent oxidoreductases (FDORs) and is widely distributed in 
mycobacterial species. We created a markerless deletion mutant of fsq and demonstrate that 
fsq is required for cell survival during hypoxia. We demonstrate through deletion and 
overexpression that fsq enhances cellular resistance to hydrogen peroxide treatment. The X-
ray crystal structure of Fsq was solved to 2.7 Å, revealing a homo-dimeric organization with 
flavin adenine dinucleotide (FAD) bound non-covalently. The Fsq structure uncovered no 
potential substrate binding cavities, as FAD is fully enclosed, and electrochemical studies 
indicated that the Fsq:FAD complex is relatively inert and does not share properties common 
to electron-transfer proteins. Taken together, our results suggest that Fsq modulates the 
formation of reactive oxygen species by sequestering free FAD during recovery from 
hypoxia, thereby preventing the cofactor from undergoing autoxidation to produce reactive 




 Introduction  
 
Mycobacteria are obligately aerobic bacteria that are able to survive prolonged periods of 
hypoxia and nutrient limitation. One of the key challenges for mycobacterial persistence 
during hypoxia is combatting the generation of reactive oxygen species (ROS) during re-
entry into aerobic conditions and ensuing growth. The majority of ROS production in 
mycobacterial cells is generated through the autoxidation of molecules with sufficient 
electrochemical potential to form superoxide (Miller et al. 1990). Flavins, which include 
FAD, are one class of molecules that have sufficient potential to autoxidise (in the presence 
of light or metal ions) (Miller et al. 1990, Massey 1994). In mycobacteria, autoxidation of 
flavins generates superoxide, which is subsequently converted into hydrogen peroxide by 
superoxide dismutase. Catalase then in turn catalyses the decomposition of hydrogen 
peroxide to water and oxygen (Piddington et al. 2001, Ng et al. 2004). Mycobacteria also 
have a range of other strategies to detoxify ROS, for example using a phenolicglycolipid 
present in their cell wall to scavenge ROS and mycothiol to reduce disulfide bonds (Neill and 
Klebanoff 1988, Flynn and Chan 2001, Buchmeier and Fahey 2006). 
 
In mycobacteria, a conserved mechanism in the adaptation to low oxygen is the activation of 
the two-component regulatory system DosR-DosS/DosT. The histidine kinases DosS and 
DosT use a heme group to sense the redox state and oxygen concentration of the cell (Kumar 
et al. 2007, Sousa et al. 2007). Both kinases in turn phosphorylate DosR, a LuxR-type helix-
turn-helix transcriptional activator that binds 18-bp palindromic sequences in promoter 
regions (Florczyk et al. 2003, Park et al. 2003, Wisedchaisri et al. 2008). In the fast-growing 
soil bacterium Mycobacterium smegmatis, the dos system controls 11 operons and 49 genes 





Fsq is among the mycobacterial proteins of the dos regulon and is highly upregulated under 
hypoxia (Berney et al. 2014). Fsq has recently been identified as belonging to a diverse and 
largely uncharacterized superfamily of flavin/deazaflavin oxidoreductases (FDORs) that are 
abundant in mycobacteria and other Actinobacteria (Ahmed et al. 2015, Ahmed et al. 2016). 
This superfamily is characterised by a split beta barrel structural fold that generally binds 
flavin/deazaflavin cofactors. The FDOR superfamily can be further split into two families: 
the FDOR-A family that all have F420 as a cofactor and the more diverse FDOR-B family that 
can bind F420, FAD or FMN as cofactors, or heme as a substrate. The FDOR-B family exhibit 
diverse functions, including pyridoxine 5'-phosphate oxidases (PnPOxs), biliverdin 
reductases, and heme oxygenases (Ahmed et al. 2015).  
 
Understanding of physiological roles of the uncharacterised genes of the dos regulon remains 
an important goal as they may provide insight into the unique mechanisms of adaptation 
these bacteria have evolved in order to survive both the stress of entry into hypoxia and re-
entry into aerobic growth conditions during their normal life cycle. In this communication, 
we determined the role of Fsq in adaptation to hypoxia through a combination of 






2.3.1 Strains and growth conditions.  
All organisms, strains and plasmids used in this study are listed in Supplementary Table 2.1. 
M. smegmatis mc2155 was grown in either lysogeny broth with 0.05% Tween 80 (LBT) or 
Hartmans de Bont (HdB) minimal medium (Smeulders et al. 1999) supplemented with 0.05% 
tyloxapol and either 22 mM glycerol or 30 mM succinate as the sole carbon and energy 
source. When required, medium was supplemented with 20 µg/mL kanamycin, 50 µg/mL 
hygromycin, or 5 µg/mL gentamicin. If solid medium was required, 1.5% agar LB 0.05% 
Tween 80 was used. Aerobic growth was carried out in flasks of 125 mL with 25 ml medium 
or 250 mL with 50 ml medium in rotary incubator shaking at 200 rpm, 37°C. Escherichia coli 
strain DH10b was grown in lysogeny broth (LB) or M9 minimal medium and, when required, 
50 µg/mL kanamycin, 50 µg/mL hygromycin, or 20 µg/mL gentamicin. M. smegmatis cells 
were grown into hypoxia using 30 ml of medium in a 120 ml serum vials using the Berney-
Cook model of hypoxia (Berney et al. 2012) where depletion of oxygen was confirmed using 
a control vial that contained methylene blue (1.5 µg/ml) that becomes colourless when low 
oxygen is present. To count colony forming units (CFU/mL), each culture was serially 
diluted in PBS (pH 7.0) and spotted onto agar plates. All survival studies were performed 
with biological triplicates, and plates were spotted in technical triplicate. Optical density was 
measured at 600 nm to monitor growth of bacteria using a Jenway 6300 spectrophotometer. 
Once optical density of cell growth was above 0.5, the cells were diluted 1 in 10 in 0.85% 
saline buffer to bring the optical density (600 nm) below 0.5. b-galactosidase assays were 




2.3.2 Sequence similarity network.  
Sequences were obtained via BLAST searches using MSMEG_5243 as the query and were 
curated with CD-Hit (Fu et al. 2012) to remove sequences with more than 90% identity. 
Sequence similarity networks were obtained using an all-versus-all BLAST of the curated 
sequences as described previously (Ahmed et al. 2015) using BLAST+ (Camacho et al. 2009) 
Networks were visualised in Cytoscape 3.6.1 (Doerks et al. 2002) with nodes coloured 
according to taxonomic order and BLAST E-values used as the edges. 
 
2.3.3 Markerless deletion mutant construction.  
In brief, to generate the deletion of fsq, two homologous regions either side of the target gene 
were generated and fused together using overlap extension PCR (Primers LH1, LH2, LH3, 
LH4) (Supplementary Table 2.2) and cloned into pX33 using the SpeI restriction enzyme 
(NEB). For the deletion of MSMEG_6368, following the initial PCR that generated the two 
homologous regions either side of target gene (Primers LH7, LH8, LH9, LH10) 
(Supplementary Table 2.2), we used Gibson cloning (NEB) as per the manufacturer’s 
instructions to join the homologous regions to pX33. The pX33 construct with homologous 
regions was then electroporated into M. smegmatis and grown at 28°C to ensure 
permissibility of the pX33 temperature sensitive plasmid. Confirmation of the plasmid in the 
cell was achieved by treating cell colonies with 250 mM catechol, which causes any colonies 
containing the plasmid to turn yellow, owing to the catechol dioxygenase produced by pX33. 
Following confirmation of the plasmid presence, the cells were grown on liquid media at 
28°C and then plated at 40°C to force integration based on the homology of the gene flanking 
regions. Integrants were confirmed through catechol screening (as above). Integrants were 
then spread-plated on sucrose (10% w/v) containing media to force recombination to either 
the wildtype genotype or the markerless deletion mutant. All mutants were confirmed using 
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whole genome sequencing (WGS) and aligned using Geneious to an isogenic wild-type to 
confirm that the gene was deleted. 
 
2.3.4 Expression and purification of Fsq.  
The vector encoding Fsq includes an N-terminal His-tag followed by a TEV protease 
cleavage site, as described previously (Ahmed et al. 2015). Escherichia coli BL21(DE3) 
(Invitrogen) cells were transformed with the pETMCSIII vector containing the Fsq construct 
using electroporation. Colonies were picked and grown in 5 mL starter cultures before being 
transferred to 1 L modified autoinduction media (5 g yeast extract, 20 g tryptone, 85.5 mM 
NaCl, 22 mM KH2PO4, 42 mM Na2HPO4, 0.6% glycerol, 0.05% glucose, 0.2% lactose and 
100 µg/ml ampicillin) and grown for 16 h at 30 °C before centrifugation at 4000 × g for 15 
minutes and removal of supernatant. Cell pellets were frozen and resuspended in 40 mL of 
buffer A (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 25 mM imidazole) before being ruptured 
by sonication on ice. Turbonuclease (0.1 μl) (Sigma-Aldrich) was added prior to pelleting 
cell debris by centrifugation at 20 000 × g for 60 minutes. The resulting supernatant was then 
loaded onto a 5 mL HisTrap nickel affinity column (GE Healthcare) pre-equilibrated with 
buffer A. The column was washed with 25 mL of buffer containing 25 mM imidazole, 25 mL 
of 8% B (43 mM imidazole) and eluted in 100% B (250 mM imidazole). The eluted protein 
was then passed over a GE HiPrep 26/10 desalting column to buffer exchange into 50 mM 
Tris-HCl, 200 mM NaCl, pH 8 and His-tag was cleaved by incubating the eluent overnight 
with TEV protease (purified in-house) (Cabrita et al. 2007), 1 mM DTT and 0.5 mM EDTA. 
The cleaved His-tag and TEV protease were then removed by passing the reaction mixture 
over a 5 mL HisTrap nickel affinity column and collecting the flow-through. The sample was 
concentrated by centrifugation in an Amicon Ultra-15 10 MWCO spin filter at 4000 × g to a 
final volume of 2 mL and further purified by size exclusion chromatography (SEC) using a 
GE Hiload 16/600 Superdex 75 pg column with buffer containing 20 mM HEPES, 150 mM 
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NaCl, pH 7.5. The final sample was diluted to adjust buffer concentration to 20 mM HEPES, 
50 mM NaCl, pH 7.5, and concentrated to 1.3 mM for storage at 4 °C. 
 
2.3.5 X-ray crystallography.  
High-throughput screens from Hampton Research were used to identify initial crystal 
forming conditions for Fsq using the 1.3 mM protein solution. Crystals grew in 20% 
polyethylene glycol 1500, 4% 2-methyl-2,4-pentanediol and 0.1 M citric acid pH 3.5. Using 
the same conditions as a cryobuffer, data was collected in house with a Xenocs GeniX 3D Cu 
HF microbeam X-ray generator and a MAR345 plate detector. The diffraction data were 
integrated using XDS (Kabsch 2010) and AIMLESS (Evans and Murshudov 2013) as part of 
the CCP4 suite (Collaborative Computational Project 1994), was used for scaling. This was 
followed by molecular replacement with Phaser (McCoy et al. 2007) using the structure of a 
related protein of unknown function from Corynebacterium glutamicum (PDB ID: 3FKH), 
which has 45% amino acid sequence identity to Fsq. Initial model building was performed 
using Buccaneer (Cowtan 2008), followed by manual model building in Coot (Emsley et al. 
2010). Refinement was performed with Refmac 5.5 (Murshudov et al. 2011) and PHENIX 
1.13_2998 (Adams et al. 2010).  Omit mFo-DFc electron density was used to model the 
position of bound FAD molecules.  
 
2.3.6 DNA manipulation and cloning.  
All molecular biology techniques were carried out according to standard procedures. All 
restriction enzymes and DNA modifying enzymes used were from New England Biolabs 
(NEB) and were in their appropriate buffers. All constructs were confirmed using either PCR 
or restriction digests followed by sequencing. PCR for construct creation was done using 
Thermo Fisher Phusion polymerase following the recommended conditions with appropriate 
annealing temperatures and extension time. The construct for fsq tetracycline (pLH2) 
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inducible expression was made using the pMIND vector backbone as previously described 
(Blokpoel et al. 2005) with an artificial ribosome binding site (Robson et al. 2009) using the 
primers LH5 and LH6 to amplify fsq for cloning (Supplementary Table 2.2).  
 
2.3.7 Quantitative reverse transcriptase PCR (qRT-PCR).  
Total RNA was extracted using TRIzol (Ambion) as per the manufacturer’s instructions and 
then purified using the RNA Clean and Concentrator kit (Zymo) as per the manufacturer’s 
instructions. The cells were lysed by three cycles in a mini-Beadbeater (Biospec Products) at 
4800 rpm for 30 s and held on ice between each of the cycles. DNA was removed by 
treatment with 3 U RNase-free DNase using the TURBO DNA-free kit (Ambion) as per the 
manufacturer's instructions. The RNA concentration was determined using a NanoDrop One 
spectrophotometer. Reverse transcriptase PCR was performed using SuperScript III 
(Invitrogen), according to the manufacturer's instructions for cDNA synthesis. After cDNA 
synthesis, qPCR was carried out using Platinum SYBR Green qPCR SuperMix-UDG with 
ROX (Invitrogen). The qPCR reactions were carried out on a QuantStudio 6 (Applied 
Biosystems). As an internal control and for the normalization of results the gene sigA was 
used. Error bars are representative of biological triplicate. Primers used are listed in 
Supplementary Table 2.2 (MSMEG_6368 = LH11, LH12, fsq = LH13, LH14, tgs1 = tgsfw, 
tgsrev). 
 
2.3.8 Hydrogen peroxide challenges.  
Cells were grown in HdB minimal media with glycerol as the sole carbon and energy source. 
Cells were then harvested and resuspended in PBS (PH 7.5) with 0.05% tyloxapol normalised 
to an OD600 of 1.0 and then treated with 20, 50 or 75 mM hydrogen peroxide and left shaking 
at 180 rpm at 37°C for 3 hours. Cells were then plated using serial dilutions 5 µL spots on 
LBT solid media to determine cell viability.  
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2.3.9 Electrochemistry.  
Cyclic voltammetry was carried out using a BASi Epsilon potentiostat with a C3 cell stand. A 
three-electrode system was employed comprising a modified glassy carbon electrode as 
working electrode, Pt wire counter and Ag|AgCl|saturated NaCl reference electrode. All 
potentials are quoted versus the normal hydrogen electrode (NHE), calculated as Ag/AgCl + 
196 mV. The working electrode was prepared by polishing according to the manufacturer’s 
instructions using 0.05 mm alumina polish, followed by sonication for 5–10 minutes in 
MilliQ water. Carbon nanotubes (single walled COOH-functionalised 1-2 nm, 
Nanostructured & Amorphous Materials, OD 1-2 nm) were dispersed in MilliQ water using 
sonication to give a concentration of 1 mg/mL. SEC-purified Fsq (~1 µM) was mixed with an 
equal volume of nanotube suspension and applied directly to the freshly polished electrode 
surface and allowed to dry at ambient temperature. Films prepared with protein-free FAD 
were used as controls. Oxygen was removed from the buffer through purging with argon. 
 
2.3.10 Accession numbers  




 Results and Discussion 
 
2.4.1 Homologues of Fsq are highly conserved among mycobacteria.  
A previous bioinformatics analysis of the diverse superfamily of flavin and deazaflavin-
dependent oxidoreductases (FDORs) placed Fsq within a discrete FAD-binding sub-family 
alongside MSMEG_6368 and rv3129 from M. tuberculosis (Ahmed et al. 2015). We 
compared the genetic organisation, expression levels, and primary sequences of Fsq and 
MSMEG_6368 to gain insight into their possible cellular roles. Based on pairwise alignment, 
Fsq shares 64% amino acid identity with rv3129 and 54% identity with MSMEG_6368. The 
fsq and rv3129 genes are both part of the dosR regulon and share similar genomic contexts, 
with both being in the same region as dosR (Figure 2.1a). Conversely MSMEG_6368 is not 
part of the dosR regulon and does not share the same genomic context as fsq (Berney et al. 
2014). qRT-PCR confirmed that fsq but not MSMEG_6368, is upregulated by 4.7-fold under 
hypoxia (p = 0.003) (Figure 2.1b). The tgs1 gene encoding the TAG synthase 1, a gene 
known to be controlled by DosR, was upregulated 2.3-fold under hypoxia (Figure 2.1b). 
 
A sequence similarity network (SSN) was used to examine the FAD-binding subfamily that 
includes Fsq and MSMEG_6368 in greater detail than in our previous study (Ahmed et al. 
2015). We initially truncated the dataset such that sequences with less than 70% coverage and 
less than 30% identity to Fsq were excluded from analysis. This gave an initial network of 
1124 nodes, which formed a large group without application of a logE filter (Figure 2.1c). 
Several small groups (primarily consisting of sequences from orders other than 
Corynebacteriales and Micrococcales) separate out when only edge scores with logE < -36 
were considered (Figure 2.1d). The main cluster contained nodes including FSQ, 
MSMEG_6368 and rv3129. When edges were further filtered to logE < -53 a large cluster 
containing only sequences from Corynebacteriales becomes apparent (Figure 2.1e). The 
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mycobacterial sequences represented include slow-growing pathogenic species such as 
M. tuberculosis, M. kansasii and M. canettii, as well as fast-growing species such as 
M. wolinskyi, M. phlei and M. fortuitum, suggesting that Fsq homologs are highly conserved 
throughout mycobacterial species. Finally, when edge scores with logE < -67 were 
considered a cluster containing MSMEG_6368 separates from Fsq and Rv3129. The high 
level of sequence conservation among this final group of homologs, across such a large 
number of mycobacterial species, suggests that Fsq and Rv3129 are under strong selective 
pressure to maintain a physiological function (Figure 2.1f), and therefore are proposed to be 
flavin sequestering family proteins (FSFP). In contrast, MSMEG_6368 appears to be less 





Figure. 2.1. Organisation, regulation and abundance of Fsq.  
(a) Genomic context of fsq in M. smegmatis and its homolog Rv3129 in M. tuberculosis. 
Matching colours between M. smegmatis and M. tuberculosis represent homologous genes. 
Gene sizes are not to scale. (b) Comparison of expression ratio of MSMEG_6368 and fsq, 
with tgs1 as a positive control, from cells harvested at 6 days growth in aerobic and hypoxic 
conditions. The gene sigA was used as the reference. Error bars represent standard deviations 
of biological triplicates. Statistical testing was performed using an unpaired student’s t test, 
where ** = p < 0.01. (c, d, e, f). Sequence similarity networks (SSNs) of Fsq-related proteins 
are shown with different cutoffs. In an SSN, protein sequences are represented as nodes 
(dots) which are joined by edges (lines) which represent a similarity metric such as Basic 
Local Alignment Search Tool (BLAST) E-value (Atkinson et al. 2009). Nodes are coloured 
according to taxonomic order. (c) SSN with no logE cutoff applied. (d) SSN of Fsq-related 
proteins with a logE cutoff of -36. A large heterogeneous cluster containing Fsq, 
MSMEG_6368 and rv3129 separates from several small clusters. (e) The large heterogenous 
cluster examined with a cutoff of -53. A large compact cluster of mycobacterial sequences 
separates from other clusters. (f) The large cluster from previous panel with a cutoff of -67. A 
cluster containing MSMEG_6368 separates from one containing Fsq and rv3129, suggesting 
that they may have distinct functions.  
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2.4.2 fsq contributes to the survival of M. smegmatis under hypoxic growth conditions.  
To determine the function of fsq, we constructed a markerless deletion mutant strain Dfsq 
(Figure 2.2a) (Supplementary Table 2.1). The Dfsq deletion mutant was confirmed by PCR 
and whole genome sequencing. Strain Dfsq and the isogenic wild-type parent strain were 
grown under aerobic conditions on a range of different carbon sources (fermentable and non-
fermentable) and no differences in growth rate or final cell yield were observed between the 
strains (Supplementary Figure 2.1). However, when strains were grown in sealed serum vials 
that became hypoxic as cells grew (approximately 37 h), we observed a difference in the final 
optical density (600 nm) between the Dfsq mutant and the wild-type (Figure 2.2b). To 
investigate this effect in more detail, we compared the cell viability of the Dfsq mutant to the 
isogenic wild-type and a DdosR mutant during prolonged incubation under hypoxia (Figure 
2.2c). The Dfsq mutant exhibited a survival defect compared to wild-type strain from day 10 
post inoculation onwards, with the maximum difference observed being a 2-log difference at 
22 days post-inoculation (Figure 2.2c). Consistent with previous findings (Berney et al. 
2014), the DdosR mutant showed a 3-log decrease in viability after 10 days compared to 
wild-type. We were able to complement the Dfsq defect under hypoxia using complementing 
vector (pLH2, fsq+) induced with 20 ng/mL tetracycline (Figure 2.2d). After 18 days, there 
was 0.24% survival for the wild-type with an empty vector, 0.22% survival for 
complemented Dfsq, and 0.02% survival for Dfsq mutant with an empty vector (Figure 2.2d).   
 
The loss of viability observed for Dfsq mutant cells was initially hypothesized to be caused by 
Fsq playing a role in the complete activation of DosR given the two genes are in close 
proximity (Figure 2.1a). To address this hypothesis, we determined the effect of the Dfsq 
mutation on the expression of a dos-regulated gene (hyd3-lacZ) in M. smegmatis (Berney et 
al. 2014). When the expression of hyd3-lacZ was measured in the wild-type background, 
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hyd3-lacZ was upregulated in response to hypoxia (Figure 2.2e). No upregulation of hyd3-
lacZ was observed in the ∆dosR mutant, but wild-type levels of hyd3-lacZ expression were 
observed in the Dfsq mutant, confirming that fsq did not play a role in DosR activation. 
MSMEG_6368 shares 54% identity with Fsq, but is not part of the dosR regulon, suggesting 
a distinct functional role. To investigate the functional role of MSMEG_6368 and rule out 
MSMEG_6368 compensating for the loss of fsq in the Dfsq mutant, we created a markerless 
deletion mutant of MSMEG_6368 (strain D6368) (Table S1). We then grew the D6368 
mutant and the isogenic wild-type strain on a range of carbon sources (fermentable and non-
fermentable) under aerobic conditions and found that there was no detectable difference in 
the growth rate or final cell yield (Supplementary Figure 2.2a and 2.2b). No phenotypic 
differences in growth or cell viability between the D6368 mutant and the isogenic wild-type 
strain were observed under hypoxia (Supplementary Figure 2.2c and 2.2d). We then used 
qPCR to monitor the expression of MSMEG_6368 in the wild-type and Dfsq mutant 
(Supplementary Figure 2.2e). During hypoxia, the expression of MSMEG_6368 was not 
different in the Dfsq mutant compared to the wild-type. This data suggests that 





Figure 2.2. Creation and hypoxic survival of Dfsq markerless deletion mutant.  
(a) Diagram of fsq markerless deletion construction. (b, c) Long-term survival of M. 
smegmatis wild type (WT) (blue) compared to DdosR (black) and Dfsq (red) mutants under 
hypoxic conditions. Growth was in Hartmans de Bont (HdB) minimal medium supplemented 
with 22 mM glycerol. Entry of the vials into a hypoxic state was estimated by the  
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(Figure 2.2 cont.) 
decolourisation of methylene blue (1.5 µg/mL) which occurred at 27 hours. (b) Growth 
measured using optical density at 600 nm wavelength with an average of three biological 
replicates shown with error bars representing standard deviations. Unpaired Student’s T-test 
of wild type compared to Dfsq. * = p < 0.05 at each timepoint. (c) Survival measured using 
colony forming units with an average of three biological replicates shown with error bars 
representing standard deviations. Unpaired Student’s T-test of wild type compared to Dfsq 
and wild type compared to DdosR at each timepoint. * = p < 0.05, ** = p < 0.01, *** = p < 
0.001, **** = p < 0.0001. (d) Complementation of survival defect of Dfsq mutant using 
pLH2 (fsq+) (Dfsq comp) (Red) compared to an empty vector control in wild type (WT VC) 
(Blue) and an empty vector in Dfsq mutant (Dfsq VC) (Black). Vectors were induced using 20 
ng/mL tetracycline just prior to entry into hypoxia. Survival percentage of day 18 with an 
average of three biological replicates shown with error bars representing standard deviation. 
Unpaired Student’s T-test of wild type compared to Dfsq comp and wild type compared to 
Dfsq VC. * = p < 0.05. (e) Measurement of DosR activity through hyd3 LacZ expression in 
M. smegmatis wild type (WT) compared to DdosR and Dfsq mutants under hypoxic 
conditions. Strains were grown into hypoxia in HdB with 22 mM glycerol. Entry into 
hypoxia was indicated by methylene blue (1.5 μg/mL) control vials. Samples (2 mL) were 
taken at 27, 48, 72 and 144 hours and used to preform b-galactosidase assays to assess the 
level of dosR activity. Key: Wild type (WT) blue circles; ΔdosR mutant black triangles; Δfsq 
mutant red squares; b-galactosidase activity open symbols; optical density (600 nm) closed 





2.4.3 Biochemical, structural, and electrochemical analysis suggests Fsq is a FAD-
binding protein.  
To determine the biochemical function of Fsq, we expressed Fsq in E. coli and purified the 
protein to homogeneity. Fsq had previously been demonstrated to preferentially bind to FAD 
over other structurally similar cofactors FMN and F420, with a Kd value of 3.6 µM (Ahmed et 
al. 2015). We set about testing whether Fsq could function as a flavin sequestering protein by 
solving and analysing its X-ray crystal structure and testing its electrochemical properties. 
Fsq heterologously produced in E. coli co-purified with a cofactor that has a UV-vis 
absorbance spectrum with peaks at 374 nm and 456 nm, which is consistent with FAD 
(Figure 2.3a). To confirm the identity of this cofactor, we crystallized the purified protein 
(Figure 2.3b), obtaining 2.7 Å resolution diffraction (Table 1). The crystal contained 20 
molecules in the asymmetric unit, arranged as homodimers (Figure 2.3C). Omit electron 
density (mFo-DFc) consistent with FAD was observed at the dimer interfaces/cofactor 
binding sites for 17 of these chains (Figure 2.4a and 4b). The remaining three chains had no 
FAD bound at this site, although they were part of dimers in which the other monomer was 
bound to FAD. There was no electron density to support covalent attachment of FAD to the 
protein, which is consistent with previous work showing that bound FAD can be readily 
removed from Fsq through partial unfolding-refolding (Ahmed et al. 2015).  
 
Comparison of the apo- and holo-forms of Fsq revealed a large conformational change in 
the holo-structure that allows for the accommodation of FAD (Figure 2.4a and 4b). Most 
notably, a loop region in the apo-protein forms α-helix-6 in the holo-protein, which interacts 
with the phosphate groups of FAD (Figure 2.4c and 4d). While the apo-protein contains both 
α-helix-9 and α-helix-10, the position of α-helix-9 is shifted in the holo- protein causing α-
helix-10 to unravel. This lengthens loop-a between α-helix-9 and β-sheet-7, allowing it to 
accommodate the isoalloxazine group of FAD (Figure 2.4b and 4d). This substantial change 
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upon cofactor binding is unusual for proteins of the FDOR family, as structurally 
characterised FMN- and F420-binding proteins show only slight topological differences 
between their apo- and holo-forms (Supplementary Figure 2.3) (Safo et al. 2000, Ahmed et 
al. 2015, Mashalidis et al. 2015, Ahmed et al. 2016). This structural rearrangement results in 
essentially complete enclosure of the cofactor within the interior of the protein. From the 
pairwise alignment of Fsq and rv3129 we found that the majority of the key residues were 
maintained except for a proline 45 and leucine 30, which were deleted in rv3129.  
 
Flavin/deazaflavin binding proteins can typically carry out three broad roles: enzymes that 
catalyse chemical reactions (Walsh 1980), electron transport proteins that transfer electrons 
to partner enzymes for catalysis (Buckel and Thauer 2018), or cofactor binding proteins that 
bind to and sequester or transport cofactors (Grininger et al. 2009, Liu et al. 2011, Bourdeaux 
et al. 2018). We therefore sought to test each of these hypotheses. In FDORs with known 
enzymatic activity, catalysis occurs on the Re-face of the isoalloxazine rings of their flavin 
cofactors, which is solvent accessible to allow substrate binding (Mashalidis et al. 2015, 
Ahmed et al. 2016). In contrast, for Fsq, we found that the isoalloxazine ring of FAD is fully 
enclosed by the protein, making the Re-face completely inaccessible as a substrate-binding 
site (Figure 2.4e). This is achieved by an offset parallel stacking interaction between 
the xylene (A) and pyrazine (B) rings of the isoalloxazine and Phe136 of the secondary chain 
in the dimer, while loop-a (which undergoes a conformational change upon FAD binding) 
covers the pyrimidine (C) ring with hydrophobic interactions from Trp115 from the primary 
chain (Figure 2.4F). The lack of any substrate-binding site will prevent binding or catalysis of 
small molecule substrates, making it unlikely that Fsq is an enzyme.  
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Table 2.1. Crystallography statistics for Fsq. 
Data collection   
Space group P2 21 21 
Unit-cell parameters   
          a (Å) 80.27 
          b (Å) 186.04 
          c (Å) 195.39 
          α, β, γ (°) 90, 90, 90 
Wavelength (Å) 1.5418 
Resolution range (Å)a 29.6-2.69 (2.74-2.69) 
Unique reflections 82043 
Completeness (%)a 99.9 (99.9) 
Multiplicitya 7.4 (7.3) 
Rmerge ab 0.215 (1.444) 
Rpimac 0.084 (0.565) 
Mean <I/σ(I)>a 10.5 (1.7) 
CC1/2ad 0.993 (0.551) 
solvent content (%, v/v) 45.7 
Molecules per asymmetric unit 20 
Refinement   
Reflections used 81939 
Resolution range (Å)* 29.6-2.69 (2.72-2.69) 
Rwork / Rfree*‡ 0.209/0.258  
No. of atoms (all) 20515 
Water molecules 362 
Average B-factor (Å2)   
          Main chains 44.7 
          Side chains 47.6 
          Water molecules 34.1 
          FAD molecules 46.4 
R.M.S. Deviations   
          Bond Length (Å) 0.003 
          Bond Angles (°) 0.682 
Ramachandran plot regions (%) 
          Favored 94.23 
          Allowed 4.62 
          Outliers 1.14 
PDB ID 6ECI 
a Values in parenthesis are for the highest-resolution shell 
b Rmerge = (Σh Σi |Ihi – áIhñ|) / (Σh Σi áIhñ) where áIhñ is the average intensity of i symmetry-
related observations of the unique refection h. 
c Rpim = (Σh Σi (1/(nh – 1))1/2 |Ihi - áIhñ|) / (Σh Σi áIhñ) 
d CC1/2 = linear correlation coefficient between intensities from random half-datasets 
e Rwork = Σh |F(obs) – F(calc)| / Σh |F(obs)| and 5% of the data that were excluded from the 





Figure 2.3. Fsq binds FAD as a cofactor. 
(a) UV-visible absorbance spectra comparing the cofactor co-purified with Fsq (Blue) to 
FAD (Red). (b) Crystals of Fsq bound to the co-purified FAD, with no cofactor stripping or 
additional reconstitution (40× magnification). (c) The 20 chains of apo- and holo- Fsq found 




Figure 2.4. Structure of Apo and Holo-FAD Fsq.  
(a) Side and (b) top view of the overlaid structures of apo (blue, chain P) and holo (pink, 
chain B) Fsq. The secondary chain of the dimer for both structures are shown in grey. FAD 
bound to the holo structure is shown in yellow and the electron density for the cofactor on 
both binding sites of the dimer is shown, representing the Fo-Fc omit map contoured at 3 σ. 
Key loops and α-helixes are labelled to reference (c) and (d). (c) and (d) Topology maps of 
the apo and holo structures, respectively, adapted from the cartoons generated by Pro-
origami. (e) Solvent accessible surface of Fsq showing the buried flavin moiety in the holo 
structure. (f) Residues involved in FAD binding.  
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Protein film voltammetry was employed to determine the effect of Fsq on the electrochemical 
properties of the cofactor, which could also provide insight into its physiological role. Both 
Fsq and FAD displayed a single reversible redox peak at all pH values that we tested, with no 
evidence of one-electron reductions (Figure 2.5A), as is seen in some flavin-dependent 
enzymes such as fumarate reductase (Jeuken et al. 2002). At pH 7.3, the redox potential of 
FAD was found to be -260 ± 3 mV (vs. normal hydrogen electrode, NHE), while that of 
Fsq:FAD was -246 ± 9 mV (Figure 2.5A). Thus, the redox potential of FAD is not 
substantially changed by Fsq. This is in contrast to many enzymes and electron transfer 
proteins that can alter the redox potentials more than 100 mV in either direction in order to 
carry out catalysis (Heuts et al. 2009, Segal et al. 2017). There was relatively little difference 
in the effect of pH on the redox potential of free and complexed FAD (-45 mV/pH and -39 
mV/pH unit, respectively) with no redox-linked pKa observed in the range of 3.6-7.3. This 
contrasts again with electron-transfer proteins, such as flavodoxins, that have a redox-linked 
pKa between pH 4.6-6.8 (Heering and Hagen 1996, Segal et al. 2017) (Figure 2.5B). The 
values for free FAD are consistent with previous studies of free FAD on carbon nanotube 
(CNT)-modified electrodes (Goran and Stevenson 2013). In summary, FAD appears to be 
relatively stable and unreactive when bound to Fsq, making it unlikely that this protein:flavin 
complex is involved in catalysis or electron transfer reactions, leaving the possibility that it is 





Figure 2.5. Electrochemical properties of Fsq.  
(a) Cyclic voltammograms (CV) of Fsq (Blue) and FAD (Red) adsorbed on to modified 
glassy carbon electrodes. Scans were conducted at 50 mV/s in the direction indicated by the 
arrows in 100 mM sodium phosphate pH 7.3. Oxidative and reductive peaks are labelled. The 
CV of Fsq is scaled by a factor of 7.5 for comparison. (b) Effect of pH on the redox potential 
of Fsq and FAD. Over the range tested Fsq and FAD varied by -45 mV/pH unit and -39 





2.4.4 Fsq promotes resistance to oxidative stress.  
Based on the structural and biochemical data that suggests Fsq is unlikely to have either a 
catalytic or electron-transfer role in mycobacterial physiology, and the reduced fitness of the 
Dfsq strain in hypoxic conditions, we hypothesised one benefit of FAD sequestration by Fsq 
could be the prevention of FAD autoxidation to avert superoxide formation and cellular 
damage. One of the key challenges that mycobacterial species must overcome to survive 
hypoxia is mitigating oxidative damage upon entry to and re-aeration from hypoxia. To test 
this hypothesis, we challenged the Dfsq mutant and isogenic wild-type grown in either 
hypoxia (inducing conditions) or aerobic conditions (non-inducing) with hydrogen peroxide 
(Figure 2.6). Under aerobic conditions, there was no significant difference in cell viability 
between the wild-type and Dfsq mutant in response to hydrogen peroxide challenge (Figure 
2.6A). However, under hypoxic conditions, the Dfsq mutant was significantly (p=0.0082) 
more sensitive to hydrogen peroxide challenge compared to the wild-type (Figure 2.6B). 
When fsq was overexpressed in cells using the tetracycline-inducible vector pLH2 (fsq+), we 
could protect cells from killing by hydrogen peroxide stress compared to the empty vector 
control (VC) (Figure 2.6C). These results establish the molecular process by which Fsq 
confers a fitness advantage to M. smegmatis during recovery from hypoxia. However, they do 
not explain the fitness advantage of Fsq to M. smegmatis during long-term hypoxic growth. 
Thus, while at least one physiological function of Fsq is now defined, other specific functions 





Figure 2.6. Hydrogen peroxide challenge of Dfsq deletion mutant and fsq+ expression 
strain.  
(a) Challenge of wild type (WT) compared to Δfsq with 20 or 50 mM hydrogen peroxide for 
3 hours. Cells were grown aerobically in HdB with 22 mM glycerol for 10 days before 
harvest and resuspension in phosphate buffer saline with 0.5% tyloxapol. Cells were 
normalised to 1 optical density (600 nm) before treatment. (b)  Challenge of wild type (WT) 
compared to Δfsq with 20 or 50 mM hydrogen peroxide for 3 hours. Cells were grown 
hypoxically in HdB with 22 mM glycerol for 10 days before harvest and resuspension in 
phosphate buffer saline with 0.5% tyloxapol. Cells were normalised to 1 optical density (600 
nm) before treatment. (c) Challenge of wild type (WT) either expressing fsq (fsq+) (WT 
pLH2) or a vector control (VC) (WT pMind) control induced with 20 ng-1 mL tetracycline, 
challenged with 50 or 75 mM hydrogen peroxide for 3 hours. Cells were grown aerobically to 
exponential phase n HdB with 22 mM glycerol before harvest and resuspension in phosphate 
buffer saline with 0.5% tyloxapol. Cells were normalised to 1 optical density (600 nm) before 
treatment. (a,b,c) Error bars represent standard deviation of three biological replicates. 
Unpaired Student’s T-test compared to wildtype for each treatment, where * = p < 0.05 , ** = 




2.4.5 Comparison to other cofactor-binding proteins in mycobacteria.  
Having confirmed that Fsq protects M. smegmatis against oxidative damage when emerging 
from hypoxic conditions by sequestering free FAD, we examined whether other examples of 
mycobacterial cofactor-sequestering proteins have been reported in the literature. M. 
tuberculosis and M. smegmatis have both been shown to harbour a non-functional 
nitroreductase designated Acg that has been shown to function as a flavin mononucleotide 
(FMN) storage protein or used to sequester FMN from other biochemical pathways 
(Chauviac et al. 2012). Acg is not related in sequence or structure to Fsq. However, as we 
have observed with Fsq, the Acg structure encloses (“caps”) FMN in a way to sterically 
prevent reactivity with NAD(P)H. Thus, like Fsq, Acg also appears to have evolved from a 
superfamily in which most proteins are enzymes and, under selective pressure, lost the ability 
to bind substrate to develop a cofactor-sequestration function. Notably, the acg gene is also 
regulated as part of the dosR regulon (Chauviac et al. 2012). The observation that 
mycobacteria has evolved two different proteins that each sequester flavin cofactors to 
prevent deleterious interactions, both of which are under control of the DosR regulon, 
highlights the biochemical challenges imposed by the descent into, and emergence from, 
hypoxia. These examples provide us with deeper understanding of the mechanisms that 
mycobacteria have evolved to adapt to the pressures associated with hypoxic conditions.  
 
 Conclusions  
 
Mycobacteria utilize a diverse array of flavins in a wide variety of essential electron transfer 
reactions, including FAD, FMN and F420 (Macheroux et al. 2011). Previously, it has been 
shown that mycobacteria possess proteins such as Acg to sequester FMN in hypoxic 
conditions. In this study we infer, using a combination of biochemical, structural and 
electrochemical data, that Fsq from M. smegmatis functions to sequester FAD under hypoxia. 
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The expression of fsq is controlled by DosR and mutants defective in fsq are hyper-sensitive 
to oxidative stress when recovering from hypoxia. These data suggest that the ability of Fsq 




 Supplementary data 
Supplementary Table 2.1. Strains and plasmids used in this study 
Strain or 
plasmid 
Description Source or Reference  
E. coli  
DH10B F- mcrA D(mrr–hsdRMS–mcrBC) f80dlacZ 
DM15 DlacX74 deoR recA1 araD139 D(ara 
leu)7697 galU galK rpsL endA1 nupG  
Invitrogen 
BL21 (DE3) F– ompT gal dcm lon hsdSB(rB–mB–) λ(DE3 
[lacI lacUV5-T7p07 ind1 sam7 nin5]) [malB+]K-
12(λS) 
Invitrogen 
M. smegmatis  
mc2155 ept-1, efficient plasmid transformation mutant of 
mc2 6 
(Snapper et al. 1990) 
Dfsq mc2 155 Dfsq This study 
D6368 mc2 155 DMSMEG_6368 This study 
∆dosR mc2155 with marked deletion of MSMEG_3944, 
HygR 
(O'Toole et al. 2003) 
Plasmids  
pX33 pPR23 carrying a constitutive xylE marker; Gmr+ (Gebhard et al. 2006) 




pJEM15 fused to promoter region of the Hyd3 
operon 
(Berney et al. 2014) 





T7 inducible vector for Fsq expression His-tagged (Ahmed et al. 2015)  
pLH1 pX33 containing flanking regions of fsq for 
deletion 
This study 
pLH2 pMind containing fsq gene with an artificial RBS This study 
pLH3 pX33 containing flanking regions of 






Supplementary Table 2.2. Primers used in this study.  
Underlined text represents restriction enzyme recognition site used. 















sigA fw  GACTCTTCCTCGTCCCACAC 









Supplementary Figure 2.1. Growth of M. smegmatis wild type compared to Dfsq mutant 
under aerobic conditions. 
(a) Growth on HdB with 22 mM glycerol as the sole carbon and energy source. Average 
optical density of three biological replicates shown with standard deviation.  (b) Growth on 
HdB with 30 mM succinate as the sole carbon and energy source. Average optical density of 
three biological replicates shown with error bars representing standard deviation. Wild type = 





Supplementary Figure 2.2. MSMEG_6368 does not affect growth of M. smegmatis. 
Wild type = blue circles, Δ6368 mutant = red squares (a) Growth on HdB aerobically with 22 
mM glycerol as the sole carbon and energy source. Average optical density of three 
biological replicates with error bars representing standard deviation. (b) Growth on HdB 
aerobically with 30 mM succinate as the sole carbon and energy source. Average of three 
biological replicates with error bars representing standard deviation. (c) Growth following 
entry into hypoxia measured by optical density. Average of three biological replicates with 
error bars representing standard deviation. (d) Survival following entry into hypoxia 
measured by colony forming units on agar plates. Average of three biological replicates with 
error bars representing standard deviation. (e) Comparison of expression ratio of 
MSMEG_6368 in wild-type (WT) and Dfsq mutant genetic backgrounds from cells harvested 
at 6 days growth in aerobic and hypoxic conditions. SigA was used as the reference gene. 





Supplementary Figure 2.3. Comparison of structural changes induced by cofactor 
binding between members of the FDOR superfamily. 
(a) Overlay of rv2074 complexed with citrate (2ASF, grey) and complexed with F420 (5JAB, 
blue). (b) Overlay of rv1155 apo structure (1W9A, purple) and complexed with F420 (4QVB, 
yellow). (c) Overlay of MSMEG_5243 partially complexed with FAD (OP dimer, light 
green) and fully complexed with FAD (AB dimer, gold). (d) R.M.S.D. of backbone residues 
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We have demonstrated that fsq, a DosR-regulated gene, plays a role as a reactive oxygen 
species resistance mechanism (Harold et al. 2019). Here we investigated the role Fsq has on 
proteins that harbour FAD as a co-factor (e.g. succinate dehydrogenase (Sdh)). In this 
communication we present data that suggests Fsq has the ability to affect the amount of 
flavinated Sdh. We found that overexpressing fsq caused an increased growth rate when 
succinate was the sole carbon and energy source but not with glycerol as the sole carbon and 
energy source. When Fsq was co-expressed with the SdhA subunit of Sdh1 and Sdh2 of M. 
smegmatis, Fsq lowered the flavination level of SdhA suggesting a role in Sdh flavination. 
The ability of Sdh and subcomplexes to interact with Fsq was evaluated using various 
techniques, revealing no interaction between Sdh and Fsq. In proteobacteria and eukaryote 
mitochondria, the formation of the covalent bond between the histidine of Sdh and FAD is 
facilitated by a protein known as SdhE or Sdh5 (McNeil and Fineran 2013). Using genetic 
complementation of Escherichia coli DsdhE mutants and protein expression followed by UV 
gel analysis, we found that Fsq does not function as an ortholog for SdhE. Taken together 
these data suggest that Fsq sequesters FAD in high enough concentrations to be considered to 
post translationally regulate Sdh activity levels in order to further the survival of M. 






The ability of mycobacteria to constantly adapt to a changing environment has allowed for 
the genus to become successful as both environmental and pathogenic organisms. One of the 
key drivers of oxidative metabolism is succinate dehydrogenase (Sdh). M. smegmatis has two 
succinate dehydrogenases designated Sdh1 (MSMEG_0416-MSMEG_0420) and Sdh2 
(MSMEG_1672-MSMEG_1669) (Berney and Cook 2010, Pecsi et al. 2014). Sdh2 has been 
shown to be preferentially expressed under hypoxia and is the generator of the membrane 
potential under these conditions, demonstrating that succinate metabolism plays an essential 
role in mycobacterial adaptation to hypoxia (Pecsi et al. 2014). Under hypoxic conditions, 
mycobacteria utilise the glycolate shunt to funnel carbon to succinate and malate. The 
succinate is then used by Sdh in order to maintain the membrane potential of the cell (Pecsi et 
al. 2014). In M. tuberculosis there are two Sdh (Sdh1 and Sdh2) enzymes as well as a 
fumarate reductase (Frd). Similarly, in M. smegmatis the Sdh1 enzyme is proposed to be the 
primary Sdh with Sdh2 providing assistance in maintaining the membrane potential under 
hypoxia (Watanabe et al. 2011, Eoh and Rhee 2013, Hartman et al. 2014). Despite the 
functional importance of Sdh, its regulation is poorly understood. Sdh has been shown to be 
regulated by Crp (Aung et al. 2015). Crp regulation is thought to be important for regulation 
of genes required to control metabolism under hypoxia (Aung et al. 2015). Currently there is 
no regulatory link between oxygen sensor kinases such as the DosR-S two component system 
and Sdh, meaning how Sdh is regulated in response to hypoxia is not understood.  
 
Sdh is a flavoprotein with a FAD co-factor, which catalyses the oxidation of succinate to 
fumarate. Interestingly, this FAD molecule is covalently bound to the histidine in the SdhA 
subunit, which alters its electrochemical properties more favourably for catalysis of the 
reaction (Rutter et al. 2010). In proteobacteria and eukaryote mitochondria, the formation of 
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this covalent bond is facilitated by a helper protein known as SdhE or Sdh5 (McNeil and 
Fineran 2013). The SdhE protein facilitates bond formation by holding the SdhA subunit in 
the correct anatomical position for the autocatalytic bond to form (Sharma et al. 2018). In the 
mycobacterial genus there is no homolog to SdhE and no ortholog has yet been discovered, 
leaving the question of whether mycobacterial Sdh enzymes require a chaperon to assist in 
the catalysis of the SdhA:FAD covalent bond. 
 
In addition to its catalytic role Sdh can be a significant generator of reactive oxygen species 
(ROS). Post hypoxia, Sdh has been shown to create ROS, leading us to hypothesise that Sdh 
may be a significant driver of ROS in mycobacterial cells when recovering from hypoxia. We 
have revealed that Fsq is upregulated during hypoxic growth, sequesters FAD and increased 
cell tolerance to ROS (Harold et al. 2019). We hypothesise that some of the ROS tolerance 
may be through modulation of Sdh activity. Additionally, Fsq has been shown to be widely 
conserved in mycobacterial species (Harold et al. 2019) and may still have undetermined 
physiological roles. This may further explain the deleterious hypoxia phenotypes presented in 
the Dfsq knockout strain. Here we investigate the interplay between Fsq and Sdh to elucidate 
any further functions of Fsq for the adaptation of mycobacteria to hypoxia. We examine what 
affects overexpression of fsq has on the cell, which lead us to examine if Fsq could function 
as an orthologue to SdhE. Further we determine what effect Fsq has on the flavination state 










3.3.1 Strains and growth conditions.  
All strains and plasmids are listed in Supplementary Table 3.1. M. smegmatis mc2155 was 
grown in either lysogeny broth with 0.005% Tween 80 (LBT) or Hartmans-de Bont (HdB) 
minimal medium supplemented with 0.005% tyloxapol and either 22 mM glycerol or 30 mM 
succinate as the sole carbon and energy source. When required medium was supplemented 
with 20 µg/mL Kanamycin, 50 µg/mL hygromycin, 5 µg/mL gentamicin. If solid medium 
was required 1.5% agar LBT was used. Aerobic growth was carried out in flasks of 125 mL 
with 25 ml medium or 250 mL with 50 ml medium shaking at 200 rpm. Escherichia coli 
strain DH10b or BW25113 were grown in lysogeny broth (LB) or M9 minimal media and 
when required 50 µg/mL kanamycin, 50 µg/mL hygromycin, 20 µg/mL gentamicin. M. 
smegmatis cells were grown into hypoxia using 30 ml of medium in a 120 ml serium vials 
using the Berney-Cook model of hypoxia (Berney et al. 2012) where depletion of oxygen was 
confirmed using a control vial that contained 1.5 µg/ml methylene blue that becomes 
colourless when low oxygen is present. To count colony forming units (CFU/mL), each 
culture was serially diluted in PBS (pH 7.0) and spotted onto agar plates. All survival studies 
were performed with biological triplicates, and plates were spotted in technical triplicate. 
Optical density (OD) was measured at 600 nm to monitor growth of bacteria using a Jenway 
6300 spectrophotometer. Once optical density of cell growth was above 0.5, the cells were 
diluted 1 in 10 in 0.85% saline buffer to bring the optical density below 0.5. 
 
3.3.2 Preparation of inverted membrane vesicles.  
Cells were grown in 500 mL of desired medium in a 2 L flask for aerobic or 300 mL in a 2L 
shott bottle with rubber bung for hypoxia. Cells were harvested at 4,000 rpm for 30 minutes 
and then resuspended in a lysis buffer consisting of 50 mM Tris-Cl (pH 7.5), 5 mM MgCl2, 1 
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complete protease inhibitor tablet (Sigma), 1 mM dithiothreitol, 2.5 mg DNase I. The cells 
were lysed using three passages through a cooled Stansted French press at 20,000 psi. The 
lysate was then centrifuged a 10,000 rpm for 15 minutes to remove all unbroken cells. The 
clarified lysate was centrifuged at 200,000 x g for 45 minutes. The resulting membrane pellet 
was re-suspended in the lysis buffer minus the DNaseI and protease inhibitors. The IMVs 
were used immediately or snap frozen at -80 °C with 10% glycerol. Protein concentration 
was determined using a BCA assay (Sigma) with bovine serum antigen as the standard.  
  
3.3.3 Measurement of Sdh and Ndh activity. 
 For sdh activity IMVs or pure protein was incubated at 37°C for 2 minutes in (1 mL) 50 mM 
Tris-SO4 (pH 7.5) with 2 mM KCN, 66 µM 0.33% (w/v) phenazine ethosulfate (PES) and 34 
µM 0.05% (w/v) 2,6 dichlorophenolindophenol (DCIP). The reaction was then initialised by 
the addition of 5 mM succinate. The reduction of DCIP was followed by measuring the 
absorbance at 600 nm of DCIP (e 600=19.1 mM-1 cm-1) with either a Varian Cary 50 
spectrophotometer or an Evolution 260 bio spectrophotometer (Thermofisher) (Pecsi et al. 
2014).  For Ndh-2 activity IMVs were incubated at 37°C in 50 mM Tris-SO4 (pH 7.5). Ndh-2 
activity was initiated through addition of 200 µM NADH and activity followed by measuring 
absorbance at 340 nm with either a Varian Cary 50 spectrophotometer or an Evolution 260 
bio spectrophotometer (Thermofisher). 
 
3.3.4 Expression and purification of Fsq.  
BL21(DE3) E. coli cells were transformed with the pETMCSIII-fsq vector (Supplementary 
Table 3.1) construct using electroporation. Resulting colonies were picked and grown in 
starter cultures before being transferred to 1L Terrific Broth 2.0 autoinduction media and 
grown for 16 hours at 30 °C before harvest into cell pellets. Frozen cell pellets were 
resuspended in ~40 mL of buffer A (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 25 mM 
 
 69 
imidazole) before being ruptured by sonication on ice or by a cooled Stansted French press at 
20,000 psi. 0.1 μL of Turbonuclease (Sigma-Aldrich) was added prior to pelleting cell debris 
by centrifugation. The resulting yellow-coloured supernatant was then loaded onto a 5 mL 
HisTrap nickel affinity column (GE Healthcare) pre-equilibrated with buffer A. The column 
was washed with 25 mL of buffer A containing 25 mM imidazole, then 25 mL of 8% B (43 
mM imidazole) and eluted in 100% B (250 mM imidazole).  
 
3.3.5 Expression and purification of Sdh1.  
M. smegmatis mc24517 harbouring plasmid pSM001 (Supplementary Table 3.1) was used for 
protein expression. The pSM001 construct displayed leaky expression, therefore, it was 
grown in 1L of LBT for 50 hours at 200 rpm 37°C. The resulting cells were harvested and 
then resuspended in lysis buffer (50 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 0.05% Tween 80, 1 
cOmplete mini protease inhibitor tablet per 50 mL (Sigma), 1 mg DNaseI). The cells were 
lysed using three passages through a cooled Stansted French press at 20,000 psi. The lysate 
was then centrifuged a 10000 rpm for 15 minutes to remove all unbroken cells. The clarified 
lystate was centrifuged at 200000 x g for 45 minutes. The membrane-containing pellet was 
retained and resuspended in 50 mL solubilization buffer (50 mM Tris-HCl, pH 8.0, 500 mM 
NaCl, 5 mM MgCl2, 20 mM imidazole, 1% Dodecyl β-D maltoside (DDM), 1 cOmplete mini 
protease inhibitor tablet per 50 mL (Sigma)). The suspension was incubated with agitation at 
4 °C for 1 hour. Insoluble material was removed by centrifuging the suspension (200,000 x g, 
45 minutes) and discarding the pellet. The soluble supernatant was loaded on a HiTrap-HP 
nickel affinity column, pre-equilibrated with buffer A (50 mM Tris-HCl, pH 8.0, 500 mM 
NaCl, 5 mM MgCl2, 20 mM imidazole, 0.1% DDM). Sdh1 was eluted using an imidazole 
gradient, generally isolated at ~70-100 mM imidazole and essentially pure, barring 




3.3.6 Co-expression and purification of SdhA1/A2 and Fsq. 
The sdhA subunits of both Sdh1 and Sdh2 were cloned with a 6xHis tag into pYubduet with 
and without Fsq (Supplementary Table 3.1). The resulting constructs were transformed into 
mc2 4517 for expression (Wang et al. 2010). Strain mc2 4517 containing the constructs was 
grown in LBT at 37°C, 200 rpm to 0.6-0.9 OD and then induced with 0.2% acetamide (Final 
concentration) and grown for 24h before harvest. The harvested cells were resuspended in 
NPI-10 buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8) supplemented 
with 1 mg DNaseI and 1 Complete protease inhibitor tablet (Sigma). The cells were lysed by 
three passages through a cooled Stansted French press at 20,000 psi. The lysate was then 
centrifuged a 10,000 rpm for 15 minutes to remove all unbroken cells. Aliquots of clarified 
lysate (1.5 mL) were added to 0.1 mL of pre-equilibrated Protino Ni-NTA beads and 
incubated at 4°C for 1 hour mixing. The remainder of the purification was done as per the 
Protino batch purification procedure. Two wash steps with NPI-20 buffer (NPI-10 with 20 
mM imidazole final) followed by elution with NPI-250 (NPI-10 with 250 mM imidazole 
final). 
 
3.3.7 Native gel interaction studies 
Following purification of respective proteins, proteins were mixed in different molar ratios 
and left for 30 minutes at room temperature to enable any interactions to occur. The protein 
mixture was then resolved on a 8-16% native-PAGE gel at 100V before staining with 
Coomassie blue to assess interactions. Interactions between Fsq and Sdh1/A1 in the protein 
mix were indicated by the formation of a new complex (new band) not present in the single 




3.3.8 FAD-UV analysis 
Following purification of the SdhA1/2 subunits (6xHis tag) the protein concentration was 
normalised and resolved on a either a 12.5% or 8-16% SDS-PAGE gel with Thermofisher 
prestained PageRuler protein ladder (10-180 kDa). Protein was fixed in the gel using 10% 
acetic acid and FAD was visualized using a Protein Simple AlphaImager HP. Following FAD 
visualisation, the gel was then stained using Coomassie blue. Densitometry of FAD bands 
was determined using ImageJ software to compare relative FAD amounts between samples.    
 
3.3.9 DNA manipulation and cloning  
All molecular biology techniques were carried out according to standard procedures. All 
restriction enzymes and DNA modifying enzymes used were from New England Biolabs 
(NEB) and were used in their appropriate buffers. All constructs were confirmed using either 
PCR or restriction digests followed by sequencing. PCR for construct creation was done 
using Thermo Fisher Phusion polymerase following the recommended conditions with 
appropriate annealing temperatures and extension. Constructs for co-expression of SdhA 
subunits with Fsq were made using the pYubDuet vector backbone using the primers LH15, 







3.4.1 Overexpression of fsq alters the growth rate of M. smegmatis. 
To gain new insight into the physiological function of fsq, we overexpressed fsq during 
aerobic growth using the tetracycline-inducible vector pMind (Supplementary Table 
3.1). Induction of fsq expression (pLH2) (Supplementary Table 3.1) during aerobic growth 
caused a significant increase in the specific growth rate (h-1) during exponential phase (18 to 
36 hours) on LBT (from 0.153 ± 0.002 to 0.163 ± 0.002 h-1) (Figure 3.1a and b) . An increase 
in the growth rate was also observed on HdB supplemented with succinate as the sole non-
fermentable carbon source (from 0.123 ± 0.005 to 0.152 ± 0.004 h-1) (Figure 3.1c and 
d). However, on HdB supplemented with glycerol as the sole fermentable carbon source the 
increased growth rate was abolished (Figure 3.1e and f). These data suggested that fsq may 
play a crucial role in oxidative metabolism and that the demand for fsq function becomes 
greater as oxygen becomes limiting (e.g. hypoxia).  As Sdh is one of the key drivers of 
oxidative metabolism in M. smegmatis, and because we observed a significant increase in 
growth rate on succinate as the sole carbon and energy source, we hypothesised Sdh may 
play a role in the increased growth rate. Therefore, we investigated the effect of fsq 
overexpression on Sdh expression and activity. Overexpression of fsq with pLH2 in the 
Dsdh1 mutant with succinate as the sole carbon and energy source of resulted in a 
significantly increased growth rate (from 0.135 ± 0.002 to 0.145 ± 0.002) (Figure 3.2). This 
growth rate difference is reduced compared to the growth rate difference in the wild type 
genetic background indicating that Fsq modulating Sdh mediates this increased growth rate 
and that the remaining growth rate difference is likely from Sdh2, the sole Sdh in the Dsdh1 
mutant. Sdh2 has been shown to be essential in M. smegmatis and we therefore could not 
examine the effect overexpressing Fsq had in a sdh2 knockout strain (Pecsi et al. 2014).  
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Succinate metabolism is primarily driven by Sdh, which uses a covalently bound FAD 
molecule to catalyse the oxidation of succinate to fumarate coupled to the reduction of 
ubiquinone or menaquinone. The mechanism of succinate dehydrogenase assembly in 
mycobacteria remains unknown. In E. coli, SdhE has been shown to be required for 
flavination of Sdh. SdhE works by directly binding SdhA, holding it in the correct 
conformation for catalysis of the covalent bond between the FAD and the histidine amino 
acid (Sharma et al. 2018). To test if Fsq was affecting the growth rate on succinate through 
modification of the FAD on Sdh, we determined the levels of Sdh activity in inverted 
membrane vesicles (IMVs) of cells overexpressing fsq compared to an empty vector control. 
The level of Sdh activity was approximately two-fold higher in the strain overexpressing fsq 
compared to the empty vector control (Figure 3.3a). To confirm if this effect was specific to 
Sdh activity, we tested the activity of another enzyme within the ETC that contains FAD. 
NADH dehydrogenase type II (Ndh2) is a monotopic membrane protein, that requires FAD 
for that the catalysis of NADH to NAD+. Overexpression of fsq had no effect on Ndh-
2 activity (Figure 3.3b) indicating that Fsq was specifically affecting Sdh activity and 
not Ndh. This supported the hypothesis that Fsq was having an effect (direct or indirect) on 




Figure 3.1. Expression of fsq during aerobic growth in different media. 
Wild type M. smegmatis expressing fsq (pLH2) (fsq+) (blue circles), or an empty vector 
control (pMind) (red squares) induced with 20 ng/mL tetracycline. (a) Growth curve on 
lysogeny broth with 0.05% Tween 80 measured using optical density (600 nm). (b) Specific 
growth rate values between 18 and 36 hours of the lysogeny broth growth curve. (c) Growth 
curve on HdB with 30 mM succinate as the sole carbon and energy source measured using 
optical density (600 nm). (d) Specific growth rate values between 18 and 36 hours of the HdB 
succinate growth curve. (e) Growth curve on HdB with 22 mM glycerol as the sole carbon 
and energy source measured using optical density (600 nm). (d) Specific growth rate values 
between 18 and 36 hours of the HdB glycerol growth curve. All measurements are an average 
of biological triplicate with error bars representing standard deviation. Unpaired students t 





Figure 3.2. Effect of fsq overexpression on the growth of the Dsdh1 mutant. 
M. smegmatis Dsdh1 expressing fsq (pLH2) Blue circles, or an empty vector control (pMind) 
Red squares induced with 20 ng/mL tetracycline. (a) Growth curve on HdB with 30 mM 
succinate as the sole carbon and energy source measured using optical density (600 nm). (b) 
Specific growth rate value between 18 and 42 hours of the HdB succinate growth curve. All 
measurements are an average of biological triplicate with error bars representing standard 







Figure 3.3. Effect of expression of fsq on Sdh and Ndh-2 activity. 
(a) Sdh and (b) Ndh-2 activity of IMVs from M. smegmatis expressing fsq (pLH2) (fsq+) 
(Blue) grown on lysogeny broth compared against an empty vector control (pMind) (Red). 
Cells were harvested in stationary phase at 48 hours growth (see Figure 3.1a). Average of 
technical triplicates with error bars representing standard deviation. Unpaired Students T-test 




3.4.2 Fsq does not function as an SdhE protein in E. coli. 
As Fsq had an effect on Sdh activity, and as Fsq is likely to be a FAD carrier protein rather 
than an enzyme (Chapter 2), we suspected that Fsq may act as a SdhE-type protein 
responsible for flavination of Sdh. We therefore first tested whether fsq could complement a 
DsdhE mutant in E. coli BW25113 using pETMCSIII- fsq, a vector expressing fsq driven by 
T7 polymerase promoter in conjunction with pTara, a T7 polymerase producing vector upon 
induction with arabinose (Supplementary Table 3.1). We found that after 24 hours of growth 
on succinate as the sole carbon and energy source, no complementation of sdhE occurred 
compared to a positive control of sdhE and wild type (McNeil et al. 2012) (Figure 3.4a). To 
biochemically confirm that fsq was not functioning as an sdhE gene, we assayed the effect on 
flavination of the two M. smegmatis SdhA subunits (MSMEG_0418 and MSMEG_1670) by 
expressing the SdhA subunits (FAD-containing subunit) with and without fsq in E. coli 
BW25133 DsdhE mutant and wild type genetic backgrounds. To achieve this, we 
expressed SdhA with or without fsq using the pYubduet vectors pLH4, pLH5, pLH6 and 
pLH7 (Supplementary Table 3.1) with pTARA and analysed the degree of 
SdhA flavination levels and protein expression on an SDS-PAGE gel by visualization 
using UV fluorescence and Coomassie Blue staining. We found that Fsq did not restore wild 
type flavination levels in the DsdhE mutant confirming that it was not functioning as an 
SdhE-type protein (Figure 3.4b). Closer inspection of the SDS-PAGE gels suggested Fsq 
expression caused lower flavination levels of SdhA (Figure 3.4b). A limitation of FAD-UV 
gels is they do not distinguish between FAD and other UV fluorescent molecules; however, it 
is unlikely this is having an influence on the result in this case. Interestingly, it was noted that 
the E. coli  DsdhE mutant did not have an effect on the flavination of the M. smegmatis SdhA 
subunits suggesting that mycobacteria may have an SdhE-independent mechanism for 





Figure 3.4. Evaluation of Fsq as an SdhE-type protein. 
(a) Growth of E. coli BW25113 wild type (WT) and DsdhE mutant after 24 hours with and 
without expression of Fsq (pETMCSIII-fsq) with pTara induced with 0.1% arabinose positive 
control sdhE complemented strain (pQEsdhE), wild type and an empty vector control 
(pQE80L) on M9 media with 30 mM succinate as the carbon source. Measurements are an 
average of biological triplicate with error bars representing standard deviation (b) Nickel 
affinity batch purified samples of the SdhA1 and A2 subunits from M. smegmatis in E. coli 
BW25113 wild type (WT) and DsdhE mutant induced with 0.1% arabinose resolved on a 8-





3.4.3 Overexpressing Fsq with SdhA reduces the flavination levels of mycobacterial 
SdhA subunits.   
As we had shown that Fsq was sequestering FAD, lowering the flavination levels of the 
M. smegmatis SdhA subunits in E. coli, we proposed that this effect may also be observable 
in M. smegmatis. Therefore, using the same plasmids (pLH4, pLH5, pLH6 and pLH7) used in 
E. coli, we expressed the SdhA subunits of M. smegmatis with and without Fsq in the 
M. smegmatis mc2 4570 T7 inducible strain (Supplementary Table 3.1). To analyse protein 
expression and FAD levels, 2.94 μg of batch-purified SdhA protein was resolved on an 8-
16% SDS-PAGE gel followed by visualization using UV fluorescence and Coomassie Blue 
staining (Figure 3.4). We found that when SdhA from either the Sdh1 or Sdh2 enzyme was 
co-expressed with Fsq, there was a significant reduction in the levels of FAD bound by 
the SdhA subunits compared to the untreated controls (Figure 3.5). This effect was more 
pronounced in the Sdh2 enzyme with the SdhA subunit only showing 39% relative 
intensity (ImageJ) when co-expressed with Fsq compared to just SdhA  alone (lane 7 
compared to lane 9 Figure 3.5). Fsq had less of an effect on SdhA from the Sdh1 enzyme 
with the relative intensity only reduced to 55% (lane 3 compared to lane 5 Figure 3.5). A 
limitation of FAD-UV gels is they do not distinguish between FAD and other UV fluorescent 
molecules; however, it would have had minimal impact on the reduced FAD in this 






Figure 3.5. Effect of overexpression of Fsq on SdhA flavination. 
Nickel affinity batch purified samples of the SdhA1 and A2 subunits in M. smegmatis 
mc24517 induced with 0.2% acetamide. Top: Coomassie stained SDS-PAGE gel with 
samples extracted from cells either expressing the SdhA1 (~70 kDa) or SdhA2 (~64 kDa) 
subunit with or without co-expression of Fsq (~18kDa). Marker (Lane 1) is Thermofisher 
prestained PageRuler protein ladder (10-180 kDa).  Bottom: FAD-UV imaged 
polyacrylamide gel with samples extracted from cells either expressing the SdhA1 or SdhA2 
subunit with or without co-expression of Fsq. Marker (Lane 1) is Thermofisher prestained 
PageRuler protein ladder (10-180 kDa). L = Crude cell lysate P = Nickel affinity batch 
purified samples of the SdhA1 and SdhA2 subunits from M. smegmatis. 2.94 ug of SdhA1 or 





Figure 3.6. Effect of deletion of fsq on Sdh and Ndh-2 activity under hypoxic conditions. 
(a) Sdh and (b) Ndh-2 activity of IMVs from wild type (WT) and Dfsq mutant M. smegmatis 
grown in HdB with 30 mM succinate as the sole carbon source. Cells were harvested at 48 
hours post inoculation after entry into hypoxic conditions had occurred. Average of technical 
triplicates with error bars representing standard deviation. Unpaired Students T-test where 





Given that Fsq did not appear to have SdhE activity and appeared to be sequestering FAD 
resulting in reduced FAD content of Sdh, we decided to look at the effect of an fsq deletion 
under hypoxia (the condition where it is preferentially expressed). To examine this, we grew 
wild type and Dfsq mutant cells into hypoxia and prepared IMVs to access the level of Sdh 
activity. The IMVs from the Dfsq displayed increased Sdh activity of 0.077 ± 0.005 compared 
to the wildtype 0.059 ± 0.004 (Figure 3.6) This result supported the observation that Fsq was 
sequestering FAD from SdhA proteins to inhibit its activity shown in Figure 3.5. However, 
this result was in contrast to the increased Sdh activity when fsq was overexpressed with 
pLH2 in aerobic conditions (Figure 3.3).  
 
3.4.4 No biochemical evidence of an interaction between Sdh and Fsq 
As Fsq had been shown to affect the flavination state of Sdh, we hypothesised there may be a 
direct protein-protein interaction. To establish if Fsq was having an effect on Sdh through a 
protein-protein interaction we tested if Fsq directly interacted with the Sdh1 complex or the 
SdhA1 subunit of M. smegmatis. By mixing 45 µg of purified Sdh1 or 22.9 µg of SdhA1 with 
different molar ratios of purified Fsq and resolving the proteins on a Native-PAGE (8-16%) 
we examined if a complex formed between the two proteins (Figure 3.7). We found that at 
different protein ratios, no complex was formed between either Sdh1 and Fsq or SdhA1 and 
Fsq, however, there appears to be some smearing indicating unspecific interactions (Figure 
3.7). Moreover, when Sdh and Fsq were co-expressed and batch purified the Fsq never co-
purified with either the SdhA1 or SdhA2 more than Fsq only control (Figure 3.5). We 
concluded that Fsq was not directly interacting with Sdh under the experimental conditions 






Figure 3.7. Analysis of Fsq interactions with Sdh1 or SdhA1. 
Purified Sdh1 (45 µg) or SdhA1 (22.9 µg) mixed with purified Fsq at increasing molar ratios 
(5, 10, 15, 20 µg) of Fsq in buffer (50 mM Tris-Cl, 100 mM NaCl, pH 7.5) resolved on a 
native-PAGE gel (8-16%). Sdh1, SdhA1 and Fsq used here contains FAD. Proteins were 






We have shown that overexpression of Fsq causes an increased growth rate with succinate as 
the sole carbon and energy source and lowers the flavination state of Sdh affecting its 
activity. Therefore, this work demonstrates that Fsq, a member of the dosR regulon, is a FAD 
carrier protein that has an effect on the flavination state of the two Sdh enzymes from 
M. smegmatis by sequestering FAD. The mechanism by which Fsq effects sdh flavination is 
unclear, however, our data suggest that Fsq is capable of sequestering FAD resulting in 
decreased flavination of the SdhA subunits. It is unlikely, that Fsq removes the covalent bond 
between the SdhA subunit and the FAD. We propose a model whereby Fsq is affecting the 
pool of available FAD for catalysis of the FAD-SdhA covalent bond, thereby constraining the 
ability of the cell to make new active Sdh enzymes. Previously it has been shown in 
mycobacteria that Sdh is a critical regulator of respiration (Hartman et al. 2014), which 
presents an explanation as to why overexpressing Fsq has an effect on the growth rate. We 
demonstrated that Fsq does not function as an SdhE-type protein in either M. smegmatis or 
E. coli. It remains unclear if mycobacteria possess a protein that functions like SdhE with 
SdhE proteins only found in proteobacteria and eukaryotes (McNeil and Fineran 2013). If 
there are SdhE proteins in mycobacteria, they may be significantly different as we have 
shown that E. coli SdhE has no effect in the flavination of mycobacterial SdhA1 and SdhA2. 
We observed increased Sdh activity when fsq is overexpressed, which is contradictory to the 
Fsq sequestering FAD preventing flavination of Sdh observation. We speculate that this 
could be explained by the cell compensating from the loss of active Sdh through a feedback 
loop resulting in increased expression. However, we have no evidence of this feedback loop 
occurring. The modulation of the ROS-producing Sdh presents another mechanism by which 
Fsq can mitigate ROS stress in mycobacteria when entering and exiting hypoxia. Carefully 
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regulating the amount of flavinated Sdh during periods of hypoxia will reduce total ROS 
production given the propensity of Sdh to produce ROS. 
 
Previously, mycobacteria have been shown to have Acg, a non-functional nitrite reductase 
that has been proposed to function as a flavin mono nucleotide (FMN) storage protein 
(Chauviac et al. 2012). Similar to Fsq, Acg is regulated as part of the DosR regulon and the 
protein structure caps the FMN in a way to prevent reactivity (Chauviac et al. 2012). With 
mycobacteria seemingly having a flavoprotein rich lifestyle (Macheroux et al. 2011), 
regulation of flavoprotein through proteins such as Acg and Fsq may provide the correct 
emphasis in the cell for massive physiological changes required to enter dormancy. 
Mycobacteria have also been shown to possess a dodecin, which was characterised within M. 
tuberculosis and shown to be FMN-binding with improved binding under acidic conditions 
leading to speculation that it may be involved in acid tolerance (Liu et al. 2011, Bourdeaux et 
al. 2018). Despite the differences in structure between many flavin sequestering proteins they 
share prevalence across mycobacteria and give an indication that sequestering flavin has 
some importance, however, the physiological role of the sequestering is not currently 
understood. 
 
Fsq represents a unique molecular mechanism that the obligate aerobe M. smegmatis and 
potentially other mycobacteria use to survive in an environment with low oxygen. Previously, 
it has been shown in M. smegmatis under hypoxic conditions that hydrogen cycling can be 
used to maintain the correct NAD/NADH ratio, with the hyd3 operon under DosR control 
playing an integral part (Berney et al. 2014). Similar to Hyd3, Fsq could modulate the free 
FAD pool allowing influence on an array of metabolic enzymes especially Sdh assisting in 
maintenance of the dormancy state. Sdh has been shown to be necessary for maintaining 
membrane potential under hypoxia and is speculated to be the primary driver of menaquinone 
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cycling (Pecsi et al. 2014). Fsq could therefore represent the molecular mechanism for 
balancing maintenance of the pool menaquinone/menaquinonol pool under hypoxia. 
Previously it has been thought that adaptation to changes in environmental conditions is 
mediated through changes in transcription of mRNA, however, Fsq regulation of Sdh 
represents a new paradigm whereby in addition to regulation of the transcription of Sdh by 
Crp the enzyme activity is also post transcriptionally modulated through Fsq adjusting the 





 Supplementary data 
 
Supplementary Table 3.1. Strains and plasmids used in this study. 
Strain or 
plasmid 
Description Source or Reference  
E. coli  
DH10B F- mcrA D(mrr–hsdRMS–mcrBC) f80dlacZ 
DM15 DlacX74 deoR recA1 araD139 D(ara 
leu)7697 galU galK rpsL endA1 nupG  
Invitrogen 
BL21 (DE3) F– ompT gal dcm lon hsdSB(rB–mB–) λ(DE3 
[lacI lacUV5-T7p07 ind1 sam7 nin5]) [malB+]K-
12(λS) 
Invitrogen 
BW25113 F-, DE(araD-araB)567, lacZ4787(del)::rrnB-3, 
LAM-, rph-1, DE(rhaD-rhaB)568, hsdR514 
(Baba et al. 2006) 
DsdhE BW25113 with the sdhE gene deleted marked 
with KanR 
(Baba et al. 2006) 
M. smegmatis  
mc2155 ept-1, efficient plasmid transformation mutant of 
mc2 6 
(Snapper et al. 1990) 
mc24517 ept-1, efficient plasmid transformation mutant of 
mc2 6, expression strain with T7 RNA polymerase  
(Wang et al. 2010) 
Dfsq mc2 155 Dfsq (Harold et al. 2019) 
∆dosR mc2155 with marked deletion of MSMEG_3944, 
HygR 
(O'Toole et al. 2003) 




pX33 pPR23 (Pelicic et al., 1997) carrying a 
constitutive xylE marker; Gmr+ 
(Gebhard et al. 2006) 
pMind Tetracycline inducible vector  (Blokpoel et al. 2005) 
pYubDuet T7 inducible vector with duel MCS (Bashiri et al. 2010) 
pSM001 pYUB28b containing a 4.5 kb fragment 




pETMCSIII T7 inducible vector (Ahmed et al. 2015)  
pQE-80L E. coli expression vector Qiagen 
PQEsdhE pQE with sdhE gene cloned (pMAT10) (McNeil et al. 2012) 
pTara Arabanose inducable T7 polymerase expression 
vector 




T7 inducible vector for fsq expression His-tagged (Ahmed et al. 2015) 
pLH2 pMind containing fsq gene with an artificial RBS (Harold et al. 2019) 
pLH4 pYubDuet containing sdhA1 sequence 6xHis 
tagged 
This study 
pLH5 pYubDuet containing sdhA2 sequence 6xHis 
tagged 
This study 
pLH6 pLH3 containing fsq sequence Flag tagged This study 
pLH7 pLH4 containing fsq sequence Flag tagged This study 




Supplementary Table 3.2. Primers used in this study. 
Underlined text represents restriction enzyme recognition site used. 
Primer 
Name 
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Malate metabolism in mycobacteria primarily consists of two enzymes, malate quinone 
oxidoreductase (Mqo) and malate dehydrogenase (Mdh), which catalyse the reaction of 
malate to oxaloacetate. Here we investigate the role of Mqo in Mycobacterium smegmatis, 
which lacks Mdh. We show Mqo is highly conserved within the mycobacterium genus. To 
study the function of Mqo in M. smegmatis, we created a marked deletion mutant of mqo 
(Dmqo). Using the Dmqo mutant we demonstrate deletion of mqo causes delayed growth on 
fermentable carbon sources and the inability to grow on non-fermentable carbon sources. The 
assessment of activity of members of the tricarboxylic acid (TCA) cycle and electron 
transport chain (ETC) in the Dmqo mutant relative to wild type revealed increased activity in 
succinate dehydrogenase (Sdh) and decreased activity in NADH dehydrogenase suggesting 
dysregulation in an attempt to compensate for the deletion of mqo. In comparison to the wild 
type the oxygen consumption of the Dmqo mutant was lower and the Dmqo mutant displayed 
an inability to increase oxygen consumption upon addition of the uncoupler CCCP. Growth 
of Dmqo mutant resulted in significantly lower pH levels possibly due to the secretion of 
malate. Taken together these data suggest that the deletion of mqo in M. smegmatis causes an 
incomplete TCA cycle, which results in reductive stress for the cell and an inability to 
metabolise non-fermentable carbon sources. During growth on fermentable carbon sources, 
we hypothesise that the cells use substrate level phosphorylation (SLP) for generation of a 
large proportion of their ATP, with some carbon following through the TCA cycle to extract 






Malate metabolism is critical for a functional TCA cycle. In mycobacteria there has been 
little investigation into the role that malate metabolism plays in growth and survival. There 
are two enzymes primarily involved in malate metabolism, malate dehydrogenase (Mdh) and 
malate quinone oxidoreductase (Mqo). The Mqo enzyme while associated with the 
membrane couples the conversion of malate to oxaloacetate with the reduction of quinone 
using a FAD cofactor (Imai and Tobari 1977). Mdh couples the conversion of malate to 
oxaloacetate in the cytoplasm with the reduction of NAD+ to NADH.  
 
Escherichia coli harbours a Mqo enzyme, but the primary enzyme for malate to oxaloacetate 
conversion is Mdh, and Mqo has no physiologically described role (van der Rest et al. 2000). 
In Corynebacterium glutamicum, the Mqo enzyme was identified as the primary driver of 
malate to oxaloacetate with Mdh proposed to be operating in the reductive direction due to its 
highly positive DG° (Molenaar et al. 1998, Molenaar et al. 2000). It is suspected that 
mycobacteria predominantly use Mqo as their primary malate to oxaloacetate enzyme given 
their closer relatedness to C. glutamicum. Demonstration that Mqo and Mdh combined could 
functionally compensate for (type 2) NADH dehydrogenase provides evidence that Mdh 
functions in the reductive direction in mycobacteria, further suggesting that Mqo is the 
primary driver of malate to oxaloacetate conversion in mycobacteria (Harbut et al. 2018). As 
Mdh is absent in M. smegmatis only Mqo is present to catalyse the reaction of malate to 
oxaloacetate suggesting Mdh may be less important than Mqo in M. smegmatis (Cook et al. 
2017).  
 
A greater understanding of the role Mqo plays in malate metabolism may expose weaknesses 
in mycobacterial metabolism and will expand our knowledge and fundamental understanding 
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of mycobacterial energetics. As such, we believe an M. smegmatis Dmqo mutant would 
represent a model of what would occur if both Mdh and Mqo were inhibited in M. 
tuberculosis. Therefore, in this study we investigate what the complete inability to catalyse 




4.3.1 Strains and growth conditions. 
All organisms, strains and plasmids used in this study are listed in Supplementary Table 4.1. 
M. smegmatis mc2155 was grown in either lysogeny broth with 0.05% Tween 80 (LBT) or 
Hartmans de Bont (HdB) minimal medium (Smeulders et al. 1999) supplemented with 0.05% 
tyloxapol with a stated carbon source as the sole carbon and energy source. When required, 
medium was supplemented with 20 µg/mL kanamycin, 50 µg/mL hygromycin, or 5 µg/mL 
gentamicin. If solid medium was required, 1.5% agar LBT or 7H10 0.05% Tween 80 was 
used. Aerobic growth was carried out in flasks of 125 mL with 25 mL medium, or 250 mL 
flasks with 50 mL medium, or 25 mL glass universals with 5 mL medium in rotary incubator 
shaking at 200 rpm, 37°C. Escherichia coli strain DH10b or HB101was grown in lysogeny 
broth (LB) or M9 minimal medium and when required 50 µg/mL kanamycin, 50 µg/mL 
hygromycin, 20 µg/mL gentamicin. M. smegmatis cells were grown into hypoxia using 30 
mL of media in a 120 mL serum vials using the Berney-Cook model of hypoxia (Berney et 
al. 2012) where depletion of oxygen concentration was monitored using the SP-PSt8 oxygen 
sensor spots (PreSens) in conjunction with the PreSens Microx 4 trace sensor as per the 
manufacturer instructions. To count colony forming units (CFU/mL) (i.e. cell viability), each 
culture was serially diluted in PBS (pH 7.0) and spotted onto agar plates. All survival studies 
were performed with biological triplicates, and plates were spotted in technical triplicate. 
Optical density was measured at 600 nm to monitor growth of bacteria using a Jenway 6300 
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spectrophotometer. Once the optical density of cell growth was above 0.5, the cells were 
diluted 1 in 10 in 0.85% saline buffer to bring the optical density (600 nm) below 0.5. 
 
4.3.2 Phylogeny analysis  
Mqo protein sequences were obtained from NCBI by using a blast comparision to 
M. smegmatis Mqo protein sequence against each of the respective mycobacterial taxonomic 
group used in the analysis. The Mqo proteins were then aligned using a ClustalW alignment 
with BLOSUM cost matrix (gap cost 10 extent cost 0.1). A neighbour-joining phylogenetic 
analysis was performed using Geneious with bootstraps of 1000. 
 
4.3.3 DNA manipulation and cloning 
All molecular biology techniques were carried out according to standard procedures. All 
restriction enzymes and DNA modifying enzymes used were from New England Biolabs 
(NEB) and were used in their appropriate buffers. All constructs were confirmed using either 
PCR or restriction digests followed by DNA sequencing. PCR for construct creation was 
carried out using Thermo Fisher Phusion polymerase following the recommended conditions 
with appropriate annealing temperatures and extension time. The construct for the integrated 
complementation of Dmqo was made by amplifying the mqo gene using LH25 and LH26 
before a second round of amplification using LH25 and LH27 (Supplementary Table 2). The 
resulting DNA fragment was then cloned into pDO23a using the BP recombinase (Thermo 
Fisher) (Supplementary Table 1). The resulting plasmid named pLH10 was then mixed in 
equal molar ratios with pEN12A, pEN41A and pDE43 and mixed with LR recombinase to 
generate the plasmid pLH11 (Supplementary Table 1). pLH11 was transformed into M. 
smegmatis Dmqo where it integrated into the genome to create Dmqo pLH11 (Comp mqo+) 




4.3.4 Marked deletion mutant construction  
The initial construct for creating a marked deletion of mqo was made by amplifying 
homologous regions either side of the mqo gene using the primers LH21, LH22, LH23 and 
LH24 (Supplementary Table 2). The resulting fragments were digested with Van91I (or 
isoschizomers) to give different overhangs at each end for directional cloning. The fragments 
were then placed in a four-way ligation reaction with the 3.7 kb and 1.6 kb fragments that 
result from the digestion of pYub1471 with Van91I. This ligation resulted in a vector formed 
with a hygromycin resistance gene, the sacB gene, and two gamma delta resolvase sites 
assembled between the two homologous regions called pLH9. The pLH9 vector was then 
digested with PstI and ligated into the phAE159 phage genome, henceforth referred to as 
phLH1. The phLH1 genome was packaged into DNA lambda using the Agilent lambda 
packing mix and transduced into E. coli HB101 cells. The phage genomes were confirmed to 
have the pLH9 construct within them via restriction digest with pstI and Van91I, followed by 
sequencing of the homologous regions. The phLH1 DNA was then electroporated into 
electrocompetent M. smegmatis. The M. smegmatis was recovered for two hours in 1 mL 7H9 
(no tween), then split and mixed into two 3 mL 7H9 agar overlay mixtures (7H9 powder + 
0.3% agar) and spread on 7H10 plates (no tween). The plates were incubated for two to three 
days at 30°C to allow phage growth and lysis. Resulting plaques were picked using a 5 mL 
pasteur pipette and resuspended in MP buffer (600 µL) (50 mM Tris, 150 mM NaCl, 10 mM 
MgSO4, 2 mM CaCl2, pH 7.6-7.8). The MP buffer containing the phage was split and mixed 
with two M. smegmatis cultures (600 µL), followed by mixing into two 3 mL 7H9 agar 
overlay mixtures. The overlay mixes were spread on 7H10 plates (no tween) and examined 
for plaques after two to three days at 30°C. This resulted in an increased number of plaques, 
which were harvested by pipetting 6 mL of MP buffer on the surface and shaking at 100 rpm 
for 3 hours. The MP buffer containing the phage was harvested from the plate with a syringe 
(10 mL) before being passed through a 20 µm filter to remove the bacteria. The resulting 
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sterile MP buffer with phage titre was quantified by serial dilution followed by spot plating 
onto dry M. smegmatis overlay plates. The phage amplification was repeated until a titre of 
109, 1010 phages was achieved. Wild type M. smegmatis (10 mL) was grown up in ink wells 
to an optical density (600 nm) of 0.8 to 1.0, before harvest at 4,000 rpm (3,126 x g). Cells 
were then transduced by resuspension in MP buffer containing the 1010 or 109 phages at 37 
°C (to prevent phage lysing the cell) overnight followed by plating on LB solid media with 
50 µg/mL hygromycin. Colonies with hygromycin resistance were indicative of successful 
double homologous recombination with the gene being replaced with hygromycinR-sacB 
DNA fragment. Successful marked deletion mutants were confirmed via whole genome 
sequencing. This marked deletion method is modified from Jain et al. (2014). 
 
4.3.5 Inverted membrane vesicle preparation  
Cells were grown in 500-1000 mL of desired media in a 2 L flask. Cells were harvested 4,000 
rpm for 30 minutes and then resuspended in a lysis buffer consisting of 50 mM Tris-Cl pH 
7.5, 5 mM MgCl2, 1 complete protease inhibitor tablet (Sigma), 1 mM dithiothreitol, and 2.5 
mg DNase I. The cells were broken using three passages through a cooled Stansted French 
press at 20,000 psi. The lysate was then centrifuged a 10,000 rpm for 15 minutes to remove 
all unbroken cells. The clarified lysate was centrifuged at 200,000 x g for 45 minutes. The 
resulting membrane pellet was re-suspended in the lysis buffer minus the DNase I and 
protease inhibitors. The IMVs were used immediately or snap frozen at -80 °C with 10% 
glycerol. Protein concentration was determined using a BCA assay (Sigma) with bovine 
serum antigen as the standard. 
 
4.3.6 Enzyme activity assays 
For Sdh activity, the IMVs were incubated at 37°C in (1 mL) 50 mM Tris-SO4 (pH 7.5) with 
2 mM KCN, 66 µL 0.33% (w/v) phenazine ethosulfate (PES) and 34 µL 0.05% (w/v) 2,6 
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dichlorophenolindophenol (DCIP). The reaction was then initialised by the addition of 5 mM 
succinate. The reduction of DCIP was followed by measuring the absorbance at 600 nm of 
DCIP (e 600=19.1 mM-1 cm-1) with an Evolution 260 bio spectrophotometer (Thermofisher) 
(Pecsi et al. 2014).  
 
For Mqo activity, IMVs were incubated at 37°C in (1 mL)50 mM Tris-SO4 (pH 7.5) with 66 
µL 0.33% (w/v) Phenazine ethosulfate (PES) and 34 µL 0.05% (w/v) 2,6 
dichlorophenolindophenol (DCIP). The reaction was then initialised by the addition of 7 mM 
malate. The reduction of DCIP was followed by measuring the absorbance at 600 nm of 
DCIP (e 600=19.1 mM-1 cm-1) with an Evolution 260 bio spectrophotometer (Thermo Fisher).   
 
For Ndh-2 activity, the IMVs were incubated at 37°C in 50 mM Tris-SO4 (pH 7.5). Ndh-2 
activity was initiated through the addition of 200 µM NADH and activity followed by 
measuring absorbance at 340 nm with an Evolution 260 bio spectrophotometer (Thermo 
Fisher).  
 
For Mez activity the cytosoloic fraction from the IMVs preparation was used and incubated 
in 50 mM Tris-SO4 (pH 7.5) with 10 mM malate. The reaction was initiated by the addition 
of 200 µM NADP+ followed by measuring absorbance at 340 nm with an Evolution 260 bio 
spectrophotometer (Thermo Fisher). 
 
4.3.7 Oxygen consumption measurements 
Whole cell oxygen consumption rates were determined with cells washed with MRA buffer 
(157.5 mM NaCl, 5.4 mM KCl, 15 mM [NH4]2SO4, HdB trace metals, 0.05% tween 80) 
followed by resuspension and normalisation to an optical density (600 nm) of 0.5 or 1.0 in 
MRA buffer. Washed cells (2 mL) were pipetted into the Oroboros Oxygraphy-2k before 
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being sealed and respiration initiated with the desired carbon source. Total protein 
concentration of cells was determined using BCA assay (Sigma) with bovine serum antigen 
as the standard. Oxygen consumption was normalised to the protein concentration. Cells were 
uncoupled using 5 µM carbonyl cyanide m-chlorophenyl hydrazine (CCCP). For IMVs, 0.5 
mg of IMVs was added to 2 mL of buffer (50 mM Tris-HCl, pH 7.5) before being sealed and 
initiated with either 100 µM NADH or 3.5 mM malate.  
 
4.3.8 Succinate and malate concentration measurements 
The concentration of succinate was measured using the Succinate Colorimetric Assay Kit 
from Sigma according to the manufacturer instructions. The concentration of malate was 







4.4.1 Mqo is largely conserved across the mycobacterial genus and usually co-exists 
with Mdh. 
To investigate the importance of mqo in mycobacteria, we first evaluated its distribution 
across select mycobacterial species. Using the published phylogeny (Gupta et al. 2018), we 
selected a broad range of mycobacterial species of both fast and slow growing types to 
analyse the conservation of Mqo. We found that Mqo was conserved in all of the species we 
selected except the slow growing Mycobacterium leprae (Figure 4.1a) (Supplementary Table 
4.1). With the species that had Mqo, we used pairwise alignment followed by phylogenetic 
analysis to assess the level of conservation at the protein level. We found the level of 
conservation to be high with over 59% identity maintained (Figure 4.1a) (Supplementary 
Figure 4.1a). Differences in the phylogeny based on Mqo followed previously published 
analyses on larger proportions of the genome (Gupta et al. 2018), with the fast and slow 
growing mycobacteria separating into different clades (Figure 4.1).  
 
In M. smegmatis it has been observed that they only possess Mqo and not Mdh for the 
catalysis of malate to oxaloacetate (Cook et al. 2017). Based on this report we sought to 
evaluate how widespread only harboring mqo and not mdh was within the mycobacterial 
genus. To perform this analysis, we conducted a BLAST search on each of the genomes 
previously used (above) with the M. tuberculosis Mdh protein sequence. We found that in 
addition to M. smegmatis, only Mycobacterium goodii, Mycobacterium mageritense and 
Mycobacterium brisbanense did not have an Mdh enzyme (Figure 4.1b and Supplementary 
Table 4.4). M. smegmatis and M. goodii were shown to be most closely related with one 
another suggesting their common ancestor lost Mdh (Figure 4.1). M. mageritense and 
M. brisbanense were also most closely related and appeared to be more distantly related to 
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M. smegmatis and M. goodii suggesting a second occurrence of the loss of Mdh within the 
genus (Figure 4.1). Interestingly, none of the slow growing mycobacteria had lost Mdh 
(Figure 4.1b). Overall these data suggest Mqo was important for the survival of mycobacteria 
in their niches given its high conservation across species with Mdh being of reduced 






Figure 4.1. Diversity of Mqo and prevalence of Mdh across mycobacteria.  
(a) Mqo proteins were aligned using a ClustalW alignment with BLOSUM cost matrix (gap 
cost 10 extent cost 0.1). A neighbour-joining phylogenetic analysis was performed using 
Geneious with bootstraps of 1000 with the out group of Mqo from Corynebacterium 
glutamicum (Cg). Fast and slow growing mycobacteria species are indicated. (b) Prevalence 
of Mdh was evaluated by performing a protein BLAST search with M. tuberculosis Mdh as 




4.4.2 Deletion of mqo renders M. smegmatis unable to grow on non-fermentable 
carbon sources. 
As the comparative phylogeny analysis suggested significant importance of mqo in 
mycobacteria, we decided to investigate its role in M. smegmatis. In order to investigate the 
role of mqo in M. smegmatis a deletion mutant was created with a hygromycin resistance 
marker, named Dmqo (Supplementary Table 4.1). The Dmqo deletion mutant was screened by 
the ability to grow in the presence of the antibiotic hygromycin and then whole genome 
sequencing was used to confirm the fidelity of deletion. The initial growth of the Dmqo 
mutant on LBT solid medium was slower and delayed relative to wild type with small 
colonies not forming until day 5 of growth compared to day 3 for wild type M. smegmatis. 
This gave an indication that mqo played a role in routine aerobic growth of M. smegmatis. 
Therefore, we investigated what effect deletion of mqo would have during growth on 
fermentable carbon sources. We found that on HdB with either glycerol or glucose as the sole 
carbon and energy source there was significant delay in observable growth (long lag phase) 
with it taking over 50 hours for the growth to begin compared to wild type which had already 
reached maximum optical density (600 nm) at 50 hours (Figure 4.1a and b). Additionally, the 
Dmqo mutant did not reach the same final optical density (600 nm) as wild type (Figure 4.2a 
and b). A complementation construct for mqo was created using Gateway cloning with the 
p750 promoter driving mqo expression (Li et al. 2016). Using Dmqo integrated with pLH11 
(Dmqo pLH11), we were able to partially complement the Dmqo mutant, which showed an 
intermediate phenotype between wild type and the Dmqo mutant for both the delay in growth 
and the final optical density value (Figure 4.2a and b). On LBT liquid medium, the Dmqo 
mutant displayed a similar delayed growth and an inability to reach the same maximum 
optical density as wild type compared to growth on HdB (Figure 4.2c). The greater difference 
in final optical density on LBT compared to HdB was hypothesised to be caused by a drop in 
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pH, which limited the growth more on LBT. To confirm that the growth of the Dmqo mutant 
was not the result of a genetic suppressor mutation the resulting growth from the HdB with 
glycerol was harvested and plated to achieve single colonies. The resulting colonies were 
then re-grown and had no observable difference to the regular Dmqo mutant confirming no 
genetic suppressor mutations (Supplementary Figure 4.2). 
 
The growth defect on fermentable carbon sources was hypothesised to be caused by the 
inability of the Dmqo mutant to run a functional TCA cycle. If this was the cause, the Dmqo 
mutant would be unable to grow on carbon sources which feed directly into the TCA cycle 
(non-fermentable carbon sources). Therefore, we attempted to grow the Dmqo mutant on 
HdB with either succinate, malate or acetate as the sole carbon and energy sources (Figure 
4.3). We found that after 187 hours, the Dmqo mutant was incapable of growth on any non-
fermentable carbon source (Figure 4.3). The Dmqo complement (Dmqo pLH11) once again 
displayed an intermediate phenotype with a delay in growth on all three non-fermentable 
carbon sources indicating partial complementation was achieved (Figure 4.3). 




Figure 4.2. Growth of Dmqo mutant compared to wild type and Dmqo complementation 
on fermentable carbons sources and rich growth medium (LBT). 
Growth was carried out in 25 mL glass universals with 5 mL medium. (a) Growth curve on 
HdB with 22 mM glycerol as the sole carbon and energy source. (b) Growth curve on HdB 
with 20 mM glucose as the sole carbon and energy source. (c) Growth curve on LBT. All 
growth measurements (OD600) are an average of biological triplicates with error bars 
representing standard deviation. (a,b,c) Wild type = blue circles, Dmqo complementation 





Figure 4.3. Growth of Dmqo mutant compared to wild type and Dmqo complementation 
on non-fermentable carbons sources.  
Growth was carried out in 25 mL glass universals with 5 mL medium. (a) Growth curve on 
HdB with 20 mM malate as the sole carbon and energy source. (b) Growth curve on HdB 
with 20 mM succinate as the sole carbon and energy source. (c) Growth curve on HdB with 
20 mM acetate as the sole carbon and energy source. All growth measurements (OD600) are 
an average of biological triplicates with error bars representing standard deviation. (a,b,c) 
Wild type = blue circles, Dmqo complementation (pLH11, mqo+) = black squares, Dmqo 




4.4.3 Key enzymes of the electron transport chain and TCA cycle have reduced 
activity in the Dmqo mutant. 
Slow growth of the Dmqo mutant on fermentable carbon sources relative to wild type 
suggested an inability to shuttle carbon through the TCA cycle. We decided to evaluate the 
activity of some key enzymes of the TCA cycle. We created IMVs from cells grown on LBT 
and assayed them for the enzymatic activities of Sdh, Ndh-2 and Mqo (Figure 4.4). We 
detected robust Mqo activity in the wild type and no Mqo activity in the Dmqo mutant 
(Figure 4.4a). The Dmqo complement only restored a small amount of Mqo activity (Figure 
4.4a), but this was still 5-fold higher than the Dmqo mutant. The Sdh activity was 
significantly higher (2-fold) in the Dmqo mutant compared to wild-type (Figure 4.4b). 
Surprisingly, the Dmqo mutant complement (mqo+) Sdh activity was higher than the Dmqo 
mutant (Figure 4.4b). This gave an indication that the TCA cycle was dysregulated and trying 
to compensate for the deletion of mqo. One potential compensation mechanism for the Dmqo 
mutant would be for the upregulation of the malic enzyme (Mez), which catalyses the 
conversion of malate to pyruvate conversion while reducing NADP+ to NADPH allowing for 
the completion of the TCA cycle. To assess if this was occurring, we acquired the cytosolic 
fraction from the preparation of IMVs and assayed for Mez activity. We discovered that the 
average Mez activity was significantly reduced, with the Dmqo mutant averaging 0.004 μmol 
malate oxidised min-1 mg protein-1 compared to the 0.01 μmol malate oxidised min-1 mg 
protein-1 averaged of wild type (Figure 4.5). The average Mez activity was not restored in the 
complement (Figure 4.5). This demonstrated that Mez was not compensating for the deletion 
of mqo and in fact had lower levels of activity suggesting carbon was being excreted or less 




Given this significant change in Sdh activity, a member of the ETC, we decided to test Ndh-2 
activity, as it is critical for recycling reducing equivalents and a key member of the ETC. We 
found that the average Ndh-2 activity was significantly reduced in the Dmqo mutant to 0.023 
μmol NADH oxidised min-1 mg protein-1compared to 0.115 μmol NADH oxidised min-1 mg 
protein-1 in wild type, and 0.114 μmol NADH oxidised min-1 mg protein-1 in the Dmqo 
complement (Figure 4.4c). To confirm overall respiratory activity, we assayed the oxygen 
consumption rate of the IMVs of the Dmqo mutant compared to wild type and the 
complement using NADH as the electron donor. The oxygen consumption rate (OCR) 
average of the IMVs from Dmqo was 9.22 nmol O2 min-1 mg-1 protein, significantly lower than 
the average from wild type at 42.1 nmol O2 min-1 mg-1 protein and the average from the Dmqo 
complement at 38.28 nmol O2 min-1 mg-1 protein (Figure 4.6). Taken together these results 
demonstrate that Ndh-2 activity and NADH driven respiration was reduced significantly in 
the Dmqo mutant. This indicated that the overall metabolism was altered and led to us to 
speculate that the cell may be using other methods to turnover NADH or simply slowing the 
turnover rate. Overall, these data demonstrate that deletion of mqo causes significant changes 





Figure 4.4. Respiratory enzyme activity of Dmqo mutant compared to wild type and 
Dmqo complementation. 
(a) Mqo activity of IMVs from Dmqo mutant compared to IMVs from wild type and the 
Dmqo complement (pLH11). (b) Sdh activity of IMVs from Dmqo mutant compared to IMVs 
from wild type and the Dmqo complement (pLH11, mqo+). (c) Ndh-2 activity of IMVs from 
Dmqo mutant compared to IMVs from wild type and the Dmqo complement (pLH11, mqo+). 
Average of technical triplicates with error bars representing standard deviation. One-way 
ANOVA with Tukey multiple comparisons, * = p < 0.05, ** = p < 0.01, ***=p < 0.001, 





Figure 4.5. Mez enzyme activity of Dmqo mutant compared to wild type and Dmqo 
complementation. 
Mez activity of cytosols from Dmqo compared to cytosols from wild type and the Dmqo 
complement (pLH11, mqo+). Average of technical triplicates with error bars representing 
standard deviation. One-way ANOVA with Tukey multiple comparisons, * = p < 0.05, ** = p 






Figure 4.6. Oxygen consumption of IMVs from Dmqo mutant compared to wild type 
and Dmqo complementation. 
Oxygen consumption rate of IMVs of Dmqo compared to OCR of IMVs of wild type and 
Dmqo complementation with either NADH or Malate as the energy input. Wild type = blue 
circles, Dmqo complementation (pLH11, mqo+) = black squares, Dmqo = red triangle. 
Average of technical triplicates with error bars representing standard deviation. Two-way 
ANOVA with Tukey multiple comparisons, * = p < 0.05, ** = p < 0.01, ***=p < 0.001, 




4.4.4 Oxygen consumption rate and maximum respiratory capacity are reduced with 
deletion of mqo. 
The dysregulation of the TCA and ETC enzymes in IMVs left a question over what is 
occurring in whole cells. We therefore decided to test the oxygen consumption rate (OCR) 
with a fermentable and non-fermentable energising carbon source. We discovered that with 
glycerol (fermentable) as the energising carbon source, the Dmqo mutant had an OCR of 
68.87 nmol O2 min-1 mg-1 protein, which is significantly lower than the OCR of 126.04 nmol 
O2 min-1 mg-1 protein of wild type (Figure 4.7a). The Dmqo complement (mqo+) was not 
significantly lower than wild type (Figure 4.7a) indicating the complementation was 
functioning for oxygen consumption when glycerol was used as the energising carbon source. 
When succinate was used as the energising carbon source, a larger difference was observed 
with the Dmqo mutant having an average OCR of just 8.26 nmol O2 min-1 mg-1 protein 
compared to 71.78 nmol O2 min-1 mg-1 protein of the wild type (Figure 4.7b). The 
complementation of Dmqo did not restore wild type OCR with succinate as the energising 
carbon source (Figure 4.7b). This data indicated that the Dmqo mutant was unable to utilise 
oxygen at the same rate as wild type matching the IVM data which showed a change in the 
ETC. Furthermore, this data is consistent with the ability of cells to grow on glycerol and not 
succinate as the sole carbon and energy source as there was significantly lower levels of OCR 
on succinate. 
 
To further evaluate this change in OCR we decided to test the maximum respiratory capacity 
of the cells by using CCCP to uncouple the ETC, which causes the cell to use oxygen at the 
maximum rate possible (maximal respiration). For these analyses we define the spare 
respiratory capacity of the cell as the difference between the OCR and the maximal CCCP 
activated respiration. With glycerol used as the energising carbon source, the Dmqo mutant 
displayed a maximal respiration of 87.72 nmol O2 min-1 mg-1 protein, which is not significantly 
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different from the Dmqo OCR (Figure 4.7a). The difference in respiratory capacity is 18.85 
nmol O2 min-1 mg-1 protein. (Figure 4.7a). The Dmqo maximal respiration was significantly 
lower compared to wild type, which had a maximal respiration of 293.44 nmol O2 min-1 mg-1 
protein, giving it a spare respiratory capacity of 183.55 nmol O2 min-1 mg-1 protein (Figure 
4.7a). Intriguingly, the complementation failed to restore the  Dmqo mutant maximal respiration 
to the wild type levels, or to an intermediate level, indicating the small amount of Mqo produced 
in the complement does not resolve the spare respiratory capacity issue (Figure 4.7). With 
succinate as the energising carbon source, the Dmqo mutant was more hindered showing a 
maximal respiration of 12.98 nmol O2 min-1 mg-1 protein (Figure 4.7b). Overall these OCR and 
maximal respiration changes indicate that the Dmqo mutant is under significant respiratory stress 






Figure 4.7. Oxygen consumption rate (OCR) and maximal respiration rate of Dmqo 
compared to wild type and Dmqo complement. 
(a) OCR and maximal respiration rate when 5 mM glycerol was used as the energising carbon 
source. (b) OCR and maximal respiration rate when 5 mM succinate was used as the 
energising carbon source. Average of biological triplicates with error bars representing 
standard deviation. Two-way ANOVA with Tukey multiple comparisons, * = p < 0.05, ** = 
p < 0.01, ***=p < 0.001, ***=p < 0.001, ****=p < 0.0001. OCR = blue circles, maximal 





Figure 4.8. Growth of wild type and the Dmqo mutant under hypoxia. 
Cells were grown on HdB with 22 mM glycerol as the carbon source in 120 mL serum vials 
where optical density (600 nm) and percentage oxygen concentration were measured over 
time. Average of biological triplicates with error bars representing standard deviation. Wild 
type = blue circle, Dmqo mutant = red triangles, optical density (OD) (600 nm) = solid lines 




4.4.5 Growth of the Dmqo mutant under hypoxia. 
Based on the inability of the Dmqo mutant to consume oxygen at the same rate as wild type 
we speculated that the Dmqo mutant may have been unable to pull oxygen down to low 
levels. We therefore tested the Dmqo mutant compared to wild type in the Berney-Cook 
hypoxic model and monitored the oxygen levels using oxygen sensing spots (see methods). 
We found that the oxygen level of the Dmqo mutant was consistent with the wild type at the 
same stage of growth albeit with the additional 50 hours of lag phase, eventually reducing the 
oxygen to the same level as wild type. (Figure 4.8). This illustrated that Dmqo had no effect 
on the cells ability to utilise low levels of oxygen although it took a longer time to do so due 
to the slower growth rate.  
 
4.4.6 Growth of the Dmqo mutant on fermentable carbon sources causes lower pH of 
the medium. 
The lower activity of the TCA cycle and ETC led us to hypothesise that the Dmqo mutant 
could be metabolising more of its carbon to reduced end products. Generally, when this 
occurs bacteria excrete a reduced or incompletely oxidised intermediate, which can often 
have an effect on the pH of the media. We measured the external pH of the Dmqo mutant 
compared to wild type and the Dmqo mutant complement over the course of a growth on HdB 
with 22 mM glycerol as the sole carbon and energy source. We found that the Dmqo mutant 
had a significantly lower final external pH value of 5.52 ± 0.08 compared to wild type with a 
final pH of 6.33 ± 0.02 (Figure 4.9a and b), clearly illustrating that the Dmqo mutant was 
secreting a product; or more of an acidic end product than wild type thereby reducing the pH.  
 
When mycobacterial cells are subjected to conditions that create metabolic stress (e.g. 
hypoxia) they alter their metabolism causing the secretion of succinate, an acid that lowers 
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the pH of media (Watanabe et al. 2011, Zimmermann et al. 2015). This led us to hypothesise 
that the Dmqo mutant was secreting an increased amount of succinate over wild type causing 
the lower pH levels. To examine this, we measured the final concentration of succinate 
within the supernatant from Dmqo and wild type grown on HdB with 22 mM glycerol as the 
sole carbon and energy source. We found that the concentration of succinate was not 
significantly different between wild type and the Dmqo mutant (Figure 4.10a), indicating that 
succinate secretion was not the cause of the decreased pH. We also compared secreted acetate 
levels of the Dmqo mutant to wild type and found no difference (data not shown). With 
succinate and acetate ruled out we examined the next most likely secretion product of the 
TCA cycle in malate. We found that on average the Dmqo mutant secreted malate to a 
concentration of 3.3 ± 0.883 mM which represents 20% of the carbon supplied during growth 
compared to wild type that had no detectable levels of secreted malate (Figure 4.10b). This 
secreated malate may partially explain the significantly lower pH observed during the growth 





Figure 4.9. Growth and pH of the Dmqo mutant compared to wild type and Dmqo 
complementation. 
Cells were grown on HdB with 22 mM glycerol as the carbon source in 250 mL flasks with 
50 mL medium where optical density (600 nm) and external pH were measured over time. 
Average of biological triplicates with error bars representing standard deviation. (a) Wild 
type. (b) Dmqo. (c) Dmqo complement (pLH11, mqo+).  Optical density (OD) (600 nm) = 





Figure 4.10. Measurement of the concentration of succinate and malate in the medium 
after growth of the Dmqo mutant compared to wild type. 
Cells were grown on HdB with 22 mM glycerol as the carbon source in 250 mL flasks with 
50 mL medium before supernatants were harvested at the strains maximum optical densities 
and assayed for either succinate or malate concentrations. Average of biological triplicates 
with error bars representing standard deviation. (a) Measurement of succinate within the cell-
free supernatant. (b) Measurement of malate within the cell-free supernatant. Unpaired 





 Discussion  
 
The diversity and conservation of Mqo throughout the pathogenic and non-pathogenic 
mycobacteria compels one to consider its importance in mycobacterial metabolism. In 
M. tuberculosis, and the majority of other mycobacterial species, further understanding is 
needed over the amount of compensation Mdh provides when Mqo is deleted or inhibited. 
Given that Mdh was absent in four mycobacterial non-pathogenic fast growers it may 
indicate Mdh is not required in particular environments. As the loss of Mdh appears to have 
occurred at least twice independently during evolution, this suggests Mdh is not as important 
as Mqo. However, the ubiquity of Mdh among the pathogenic slow growers suggests Mdh 
may play a role in pathogenesis. This conditional non-essentiality of Dmqo in mycobacteria is 
consistent with previous essentiality studies on M. tuberculosis (DeJesus and Ioerger 2013, 
Cook et al. 2014). 
 
The slower growth of the Dmqo mutant on fermentable carbon sources suggests that a complete 
TCA cycle is required for the maximum growth rate of M. smegmatis. The delayed start in 
growth indicates that Mqo may be important during the exit from lag phase. The inability of the 
M. smegmatis Dmqo mutant to grow on non-fermentable carbon sources shows that they require a 
complete TCA cycle in order for growth on non-fermentable carbon sources. The partial 
complementation of growth on fermentable carbon source is likely due to the low levels of Mqo 
activity restored by the complementing construct. The increased activity of Sdh in the Dmqo 
mutant may be the result of a regulatory feedback loop upregulating Sdh at the transcriptional 
level. This upregulation is possibly to assist in energy generation as the Sdh enzyme may be the 
only enzyme feeding into the ETC given the significantly reduced activity of Ndh-2 observed. 
The mqo complement is incapable of restoring wild type Sdh activity levels, however, it did 
restore Ndh-2 activity levels. This suggests that only a small amount of Mqo activity is required 
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to restore Ndh-2 activity levels, but this small amount is insufficient to fully restore Sdh activity. 
In other species, such as C. glutamicum, Dmqo mutants displayed an inability to grow without the 
addition of exogenous nicotinamide.  Whereby it was suggested to the nicotinamide caused 
higher intracellular pyridine nucleotide enabling the Mdh to function in the oxidation of malate to 
oxaloacetate (Molenaar et al. 2000). Nicotinamide is also vital to the biosynthesis of NAD+. 
Therefore, in M. smegmatis deletion of mqo may alter the use or production of nicotinamide and 
nicotinate resulting in decreased NAD+, which may result in the lower Ndh-2 activity we observe 
in the Dmqo mutant. The lack of compensation by Mez could also be explained by a decrease in 
the amount of nicotinamide. 
  
The decreased OCR of the Dmqo mutant can be explained by slower carbon flux through the 
incomplete TCA cycle causing decreased electron input to the ETC and increased reliance of 
SLP. The Dmqo mutant displayed a decrease in spare respiratory capacity for which there are two 
possible explanations. The first one is that the Dmqo mutant has lower expression levels of the 
terminal oxidases and they are already running at their maximum velocity (Vmax). The second 
explanation could be that in the Dmqo mutant, the terminal oxidases become limited for reduced 
quinone as the other primary dehydrogenases Sdh and Ndh-2 fail to keep up. We speculate that 
the second hypothesis is more likely given the significant alterations in enzymatic activity of the 
primary dehydrogenases.  
 
The alteration of M. smegmatis resulting in significantly lower pH levels when grown indicates 
the secretion of a molecule, which is acidic. In other organisms such as E. coli these fermentative 
types of growth usually result in the production of lactate or an alcohol (Clark 1989). 
Mycobacteria have been shown to be able to use lactate for growth through oxidation, however, 
while suggested to be capable of lactate reduction there is currently no evidence of this occurring 
(Boshoff and Barry 2005). Given the preference for mycobacteria to secrete succinate under 
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hypoxic conditions we were surprised our results showed that the Dmqo mutant was not secreting 
more succinate than wild type. However, this succinate secretion may only be sufficient for 
obtaining enough energy to maintain the cell, but not enough for growth. Additionally, it has been 
shown that acetate is secreted by M. tuberculosis (Rucker et al. 2015). As lactate, succinate, and 
acetate were considered to be unlikely as candidates for causing the lower pH it left us 
considering other carbon-based acids. One of these was the secretion of malate. The protein 
responsible for succinate export in mycobacteria is DctA. DctA is a dicarboxylate transporter and 
has been shown to be capable of transporting malate in other species (Youn et al. 2009). Given 
we show that Dmqo secretes malate, DctA could provide a means by which the Dmqo mutant 
could be secreting malate during growth. Energetically it makes sense to take as much carbon as 
possible through the TCA cycle and generate more energy from limited oxidative 
phosphorylation through Sdh. The levels of malate secreted by the Dmqo mutant would not be 
sufficient to cause all of the decrease in pH that is occurring given the pKa of malic acid is 3.4-
5.2. This means it is likely that the Dmqo mutant is secreting other acidic molecules to resulting in 
the lower pH. 
 
Our results demonstrate that deletion of mqo caused significant problems within the metabolism 
of M. smegmatis, specifically around the TCA cycle. The inability to grow on any carbon sources 
that directly feed into the TCA cycle suggests that an incomplete TCA cycle does not allow 
sufficient energy to be generated in M. smegmatis. The incomplete TCA cycle energy generation 
problems are likely compounded by buildup of TCA intermediates causing the enzymes to 
become inhibited further limiting energy generation potential through the TCA cycle. This could 
force M. smegmatis to more heavily rely on substrate level phosphorylation (SLP) in order to 
obtain ATP to facilitate growth. Therefore rendering the bacteria unable to grow on carbon 




In our model we hypothesise that the cause of the altered growth and energy generation in the 
Dmqo mutant is due to an increased reliance on SLP for ATP generation. This results in a slower 
metabolic flux through the TCA cycle, where any carbon going through the TCA cycle is being 
excreted as malate (Figure 4.11). This hypothesis satisfactorily explains some of the data we have 
presented, however, it is likely other mechanisms of compensation are occurring. A small amount 
of carbon would be used by pyruvate carboxylase (Pca) to create oxaloacetate for amino acid 
biosynthesis. Any amount of carbon going through the TCA cycle would be excreted as malate 
before a small amount is pushed through Mez to produce pyruvate. The carbon flowing through 






Figure 4.11. Model of carbon flow in Dmqo mutant in M. smegmatis. 




 Supplementary data 
 
Supplementary Table 4.1. Strains and plasmids used in this study. 
Strain or 
plasmid 
Description Source or Reference  
E. coli  
DH10B F- mcrA D(mrr–hsdRMS–mcrBC) f80dlacZ DM15 
DlacX74 deoR recA1 araD139 D(ara leu)7697 galU 
galK rpsL endA1 nupG  
Invitrogen 
HB101  F–, thi-1, hsdS20 (rB–, mB–), supE44, recA13, ara-
14, leuB6, proA2, lacY1, galK2, rpsL20 (strr), xyl-
5, mtl-1 
 
M. smegmatis  
mc2155 ept-1, efficient plasmid transformation mutant of mc2 
6 
(Snapper et al. 1990) 
Dmqo mc2 155 Dmqo This study 
Mycobacteria phage  
phAE159 Mycobacteria phage with deletion to allow cloning 
using PstI restriction enzyme 
(Jain et al. 2014) 
phLH1 Mycobacteria phage for the deletion of mqo 
containing pLH9 within its genome 
This study 
Plasmids  
pYub1471 Vector containing fragments for generation of 
mutants 
(Jain et al. 2014) 
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pDO23A BP recombinase destination vector for gateway 
cloning 
(Li et al. 2016) 
pEN12A LR recombinase donating vector containing rrnB 
promoter and Tet operator  
(Li et al. 2016) 
pEN41A LR recombinase donating vector containing tetR 
gene 
(Li et al. 2016) 
pDE43 LR recombinase destination vector for gateway 
cloning. KanR 
(Li et al. 2016) 
pLH9 Homologus regions each side of mqo cloned into 
pYub1471. HygR 
This study 
pLH10 pDO23A with mqo flag tagged This study 
pLH11 Duc system vector with mqo gene flag tagged cloned 







Supplementary Table 4.2. Primers used in this study. 















Supplementary Table 4.3. Presence or absence of Mqo and Mdh in slow growing 
mycobacteria. 
Species mqo mdh 
M. africanum P P 
M. avium P P 
M. bovis BCG P P 
M. europaeum P P 
M. fragae P P 
M. haemophilum P P 
M. leprae O P 
M. terrae P P 
M. tuberculosis P P 
*Presence of Mdh was confirmed by performing a protein BLAST search on each species 
with M. tuberculosis Mdh protein as query. Presence of Mqo was confirmed by performing a 




Supplementary Table 4.4. Presence or absence of Mqo and Mdh in fast growing 
mycobacteria. 
Species mqo mdh 
M. abscessus P P 
M. aurum P P 
M. brisbanense P O 
M. fallax P P 
M. fortuitum P P 
M. goodii P O 
M. komanii P P 
M. mageritense P O 
M. phlei P P 
M. septicium P P 
M. smegamtis P O 
M. wolinskyi P P 
*Presence of Mdh was confirmed by performing a protein BLAST search on each species 
with M. tuberculosis Mdh protein as query. Presence of Mqo was confirmed by performing a 




Supplementary Figure 4.1. Percentage identity of Mqo of mycobacteria compared to the outgroup C. glutamicum. 





Supplementary Figure 4.2. Regrowth of Dmqo following single colony plating. 
Growth curve on HdB with 22 mM glycerol as the sole carbon and energy source measured 
using optical density (600 nm). Average of biological triplicates with error bars representing 









 Fsq, a new paradigm in mycobacterial adaptation to hypoxia 
Flavin sequestering proteins currently have very poorly understood physiological roles, with 
some such as Acg are known to sequester FMN (Chauviac et al. 2012). Fsq and Acg have 
evolved from two unrelated protein families to share a similar flavin sequestering role under 
hypoxia in mycobacteria. It is clear that flavin sequestering is of importance for 
mycobacterial adaptation to hypoxia, allowing the cells to protect their essential co-factors 
from cellular stress and damage. Mycobacteria and other bacterial genera also commonly 
possess dodecins that can sequester various riboflavins (Liu et al. 2011, Bourdeaux et al. 
2018). Dodecins are structurally distinct from both Acg and Fsq, generally consisting of a 
complex of ten homologous proteins (Liu et al. 2011, Bourdeaux et al. 2018). Fsq, Acg and 
dodecins represent clear evidence of multiple events of convergent evolution from different 
protein families to become flavin-sequestering proteins. Given the example of convergent 
evolution, it is clear that flavin sequestering proteins must give physiological advantages to 
controlling free flavin levels under certain environmental stresses. We need to gain further 
understanding of flavin sequestering proteins physiological and molecular roles as they may 
offer unique insights into bacterial physiology and pathogenesis. 
 
We have demonstrated that Fsq represents a new way to mitigate ROS pre-emptively in 
mycobacteria by sequestering FAD and protecting it from oxidation. Ultimately, this will 
reduce the basal level of ROS formation in the cell, lowering the pressure on the post ROS 
formation machinery such as superoxide dismutase and catalase. In situations of high ROS 
formation from FAD, Fsq will reduce the levels of ROS preventing damage to DNA, 
membranes and proteins (Figure 5.1). This is particularly advantageous when the bacteria are 
recovering from stress such as starvation and hypoxia. With Fsq also influencing the level of 
flavination of Sdh, this would provide additional mitigation of ROS production from Sdh 
activity (Quinlan et al. 2012). This could function by Fsq sequestering the FAD away from 
Sdh, the site where ROS is generated, preventing the Sdh protein complex or subcomplex 
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from producing ROS (Figure 5.2a). In E. coli fumarate reductase (Frd) is expressed under 
anaerobic conditions to maximise growth in the absence of oxygen (Jones and Gunsalus 
1987). When E. coli Frd is expressed under aerobic conditions, excessive ROS is produced 
that is lethal to the cell (Imlay 1995). Fsq may prevent ROS production from the 
mycobacterial Sdh enzymes during hypoxia as an alternative to lowering the transcription 
levels, which is used on E. coli Frd.  
 
 
Figure 5.1. Model for the physiological and molecular role of Fsq. 
Fsq sequesters free FAD within the cell preventing FAD autoxidising (ROS production) 
thereby avoiding DNA, membrane and protein oxidative damage, which can result in cell 
death. 
 
Sdh in mycobacteria has been demonstrated as a critical metabolism component. Fsq 
sequestering FAD alters the levels of Sdh flavination and thereby the energy generating 
potential of the cell. This could be described as post-translational regulation of Sdh and may 
help explain the role of Fsq under hypoxia in addition to the prevention of ROS. Sdh 
flavination down regulation would help slow the metabolism of oxygen, potentially providing 
more time for the cell to adapt and maintaining longer periods with oxygen present for basal 
cell energy generation (Figure 5.2b). In addition to Sdh, there are many other proteins in 
mycobacterial metabolism including Mqo and Ndh-2 that utilise FAD as a cofactor. Fsq may 
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affect these other metabolic enzymes. This would provide a fast mechanism for lowering 
enzymatic activity of these proteins to slow overall cell metabolism when desired such as in 
hypoxia where Fsq is expressed. While we have discovered the function of one of the 
hypothetical proteins (Fsq) used by mycobacteria under hypoxia, many other proteins 
functions in hypoxia still remains to be elucidated. Therefore, other proteins present untapped 
potential for discovery of how mycobacteria adapt to hypoxia. 
 
 Mqo, a gene essential for growth on non-fermentable carbon sources 
in M. smegmatis. 
The TCA cycle is a key component of mycobacterial carbon metabolism. Previously there 
have been no reports on the role of Mqo within mycobacteria. We have demonstrated that the 
deletion of mqo causes severe delayed growth and reduced respiration on fermentable carbon 
sources. Moreover, mqo mutants fail to grow on non-fermentable carbon sources. The 
delayed growth and reduced respiration are caused by the inability of M. smegmatis to use 
malate produced in the TCA cycle, which results in the export of this malate into the growth 
media. In addition to not obtaining maximum energy from the carbon source the growth rate 
will be limited by the rate of export of malate from the cell (Figure 5.3). The Dmqo mutant 
will also likely be growth limited by the acidification (malate export) of the outside media. 
 
The ability of Mdh to compensate for Mqo function in M. tuberculosis will need to be 
evaluated to establish if inhibiting Mqo alone is enough to cause significant growth defects 
and even cell death. However, current studies have indicated mqo is non-essential in 
M. tuberculosis (DeJesus and Ioerger 2013). Recent information has suggested that Mdh is 
important under hypoxia due to it enabling the operation of a reductive TCA cycle 
(Rittershaus et al. 2018). Mqo is likely to be important under hypoxia as there is still a need 
for the TCA cycle to function in the oxidative direction to maintain precursors for various 
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essential amino acids. As Mdh is functioning in the reductive direction under hypoxia due to 
reductive stress in the cell means only Mqo is available to maintain the oxidative TCA cycle. 
Deletion or knockdown of both Mqo and Mdh would prevent M. tuberculosis from 
completing the TCA cycle. Although a double deletion would likely not be lethal in regular 
laboratory growth, we speculate it may be lethal in the host when the pathogen encounters 
hypoxia. A challenging factor in fighting M. tuberculosis infections is that many currently 
used antimicrobials cannot kill M. tuberculosis under hypoxia. We hypothesise that double 
deletion of mqo and mdh deletion in M. tuberculosis would be lethal under hypoxic 
conditions, and therefore, they present a combination drug target to overcome the challenge 
of killing hypoxic cells.  
 
 Future directions 
Our current data strongly demonstrates biochemically that Fsq is capable of sequestering 
enough free FAD in the cell to affect Sdh flavination. These results were obtained through 
the use of artificial overexpression experiments where copy number and expression level do 
not match what is occurring biologically. To more accurately demonstrate the biological 
relevance of Fsq sequestering FAD away from Sdh, we will employ a genome located tagged 
SdhA subunit in the Dfsq mutant and wild type genetic backgrounds, which will be grown 
under hypoxic conditions followed by purification and flavination state analysis as used in 
Figure 3.4. We showed no effect of Fsq on Ndh-2, which has a non-covalently bound FAD 
confirming it is unlikely that Fsq affects non-covalently bound FAD proteins. However, we 
did not examine the effect Fsq on other flavoproteins with a covalently bound FAD. This 
warrants further investigation as we have demonstrated through Sdh that covalently bound 
FAD proteins are more susceptible to the effects of Fsq sequestering properties. For future 
interaction studies, we will examine the effect of hypoxia and if Fsq without the FAD 
interacts with Sdh. Finally, while Fsq may be having these effects in the non-pathogen 
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M. smegmatis the role of the direct homolog rv3129 in M. tuberculosis must be validated to 
be consistent with the role of Fsq using similar experiments as we have done to confirm that 
Fsq function is conserved across mycobacteria. 
 
To further establish the model of what is occurring in the Dmqo mutant, metabolic analysis 
(metabolomics) should be performed to establish the concentration of the carbon metabolites 
within the TCA and other related pathways to confirm carbon flux in the wild type versus the 
mqo mutant. In addition to a metabolic analysis, RNA sequencing of mRNA would establish 
the transcriptional adaptations which occur to allow Dmqo to grow. Together metabolomics 
and RNA sequencing would allow us to precisely pinpoint the mechanisms by which Dmqo is 
able to grow. Currently, the protein structure of Mqo remains unsolved, resolving the 
structure through X-ray crystallography and cryo-electron microscopy would add significant 
knowledge as to how Mqo functions. Evaluation of the roles of both Mdh and Mqo in 
M. tuberculosis metabolism is required to increase our understanding of mycobacterial 
metabolism.  
 
Overall it is clear that both Fsq and Mqo are important for mycobacterial adaptation and 
metabolism. Both proteins use FAD as a co-factor for their respective roles and illustrate the 
importance of flavoproteins to mycobacteria. In this thesis, we have shown that Fsq plays a 
role in ROS production avoidance and modulation of Sdh in M. smegmatis. Furthermore, we 
show that Mqo plays a critical role in oxidative metabolism in M. smegmatis. Given that 
flavoproteins represent between 0.1 and 3.5% of all predicted genes (Macheroux et al. 2011) 
gaining new understanding into their roles is critical for a greater understanding of 




Figure 5.2. Potential role of Fsq in controlling flavination of Sdh under hypoxia. 
(a) Fsq sequesters the FAD molecule away from either the complete Sdh complex or just the 
A and B subunits thereby preventing their autoxidation and ROS production. (b) Fsq 
sequesters the FAD from Sdh preventing the oxidation of succinate to fumarate thereby 





Figure 5.3. Potential model of carbon flow in the Dmqo mutant in M. smegmatis. 
The carbon enters the cell in the form of glycerol before undergoing glycolysis to generate 
some energy through SLP. The carbon then flows either into the TCA cycle where it is used 
for creation of biomass and energy. In the Dmqo mutant, the TCA cycle is non-cyclic, and 
malate is excreted from the cell lowering the external pH. Growth on glycerol occurs in the 
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